Literature Review: Heat Exposure and Longevity: From Sauna to Cellular Stress Response

This systematic review synthesizes evidence from over 50 studies to establish a mechanistic link between repeated heat exposure and enhanced longevity. Epidemiological data robustly associate habitual sauna use, optimally at four to seven weekly sessions, with reduced all-cause and cardiovascular mortality. At the cellular level, heat exposure acts as a hormetic stressor, inducing heat shock proteins that sustain proteostasis, attenuate inflammation, and support mitochondrial quality control—key pathways implicated in aging. Human acclimation studies show that core temperature elevation drives this HSP70 response, whether from exercise or passive heat, with adaptations stabilized through epigenetic chromatin remodeling. This thermal stress engages the same conserved geroprotective pathways, including autophagy and reduced inflammaging, targeted by pharmacological agents like rapamycin. Effective protocols typically involve 80–100°C for 15–20 minutes, with most cardiovascular adaptations achievable within a week. The review positions heat exposure as a viable, non-pharmacological intervention within preventive medicine and combinatorial geroscience, while calling for rigorous randomized trials to standardize protocols and validate aging biomarkers across diverse populations.

1. Introduction

The relationship between heat exposure and human health spans millennia of cultural practice, from Finnish sauna traditions to Roman thermae, yet only in recent decades has rigorous scientific inquiry begun to illuminate the precise biological mechanisms underlying these ancient intuitions. As populations across the industrialized world face rising burdens of cardiovascular disease, neurodegeneration, and age-related functional decline, interest in accessible, low-cost lifestyle interventions has intensified considerably. Repeated heat exposure — whether through sauna bathing, hot water immersion, or controlled thermotherapy — has emerged as a particularly promising candidate, generating a body of evidence that spans epidemiological cohort studies, molecular biology, and model organism research [1, 2]. What distinguishes the current moment in this literature is not merely the accumulation of findings, but a growing convergence between population-level observations and mechanistic cellular science, creating conditions under which a unified framework may, for the first time, be within reach.

At the epidemiological level, large prospective studies conducted over the past two decades have documented striking associations between habitual sauna use and reduced all-cause mortality, cardiovascular events, and neurodegenerative outcomes [3, 4, 5, 6]. These epidemiological findings have prompted investigators to ask whether the observed benefits reflect genuine biological protection or confounding by the socioeconomic and behavioral profiles of regular sauna users [7, 8]. Answering this question demands recourse to the molecular and cellular sciences, where parallel lines of investigation have been mapping the intracellular consequences of transient heat stress with increasing precision. Central to this cellular story are the heat shock proteins, a family of molecular chaperones that are rapidly induced by thermal and other proteotoxic stressors and whose functions span protein folding, disaggregation, and targeted degradation [9, 10]. Understanding how these proteins operate — and how their expression is regulated — has become essential to explaining why brief episodes of controlled heat stress might confer lasting health benefits.

The transcriptional regulation of the heat shock response is itself a story of considerable biological complexity. Heat shock factor 1 serves as the master regulator of this response, coordinating a rapid and highly orchestrated genomic program in response to proteotoxic challenge [11, 12]. Recent discoveries regarding the post-translational control of this factor, its interactions with chromatin architecture, and its roles beyond canonical heat stress have substantially revised earlier models and raised new questions about how this pathway intersects with aging biology more broadly [12, 13]. These questions become especially pressing in the context of proteostasis — the integrated network of mechanisms by which cells synthesize, fold, traffic, and degrade proteins [14, 15]. There is now compelling evidence that proteostatic capacity declines progressively with age, contributing to the accumulation of misfolded proteins that underlies conditions ranging from Alzheimer’s disease to sarcopenia [14, 16]. Whether heat exposure can meaningfully slow or partially reverse this decline is a question the field has only recently begun to address systematically.

Framing these observations is the broader concept of hormesis — the well-characterized biological principle whereby mild, transient stress elicits adaptive responses that strengthen organismal resilience [17, 18]. The hormesis paradigm offers a coherent conceptual foundation for understanding why repeated heat exposure, which is by definition a stressor, might produce net protective effects rather than cumulative harm. The dose-dependence, timing, and individual variability of these hormetic responses remain active areas of investigation, with important implications for translating laboratory findings into clinical and public health recommendations. Notably, the geroscience field has increasingly recognised that several pharmacological interventions now in clinical development — including mTOR inhibitors, NAD⁺ precursors, senolytics, and caloric restriction mimetics — engage the same conserved molecular pathways activated by hormetic heat stress, raising the question of where heat exposure sits within this broader intervention landscape and whether combinatorial strategies might offer additive benefit [19, 20].

Complementing human and cellular research, the nematode Caenorhabditis elegans has provided a powerful and genetically tractable model system for dissecting the longevity pathways engaged by heat stress [21, 22, 23]. Experiments in this organism have established causal links among heat shock factor activity, proteostasis, and lifespan extension that would be technically or ethically impossible to demonstrate directly in humans [21, 24].

This systematic review synthesizes findings from over fifty studies published between 2003 and 2025, organized around six thematic domains that together span the full arc from population health to molecular mechanism. The review addresses four guiding research questions: what molecular pathways mediate the health effects of repeated heat exposure; what the epidemiological evidence reveals about sauna use and mortality outcomes; how heat shock proteins contribute to cellular maintenance and longevity; and what heat exposure protocols appear most effective and for which populations. The thematic structure moves from epidemiology and clinical applications of passive heat therapy, through the molecular biology of heat shock proteins and HSF-1 regulation, into the broader decline of proteostasis in aging, the hormesis framework, and finally the mechanistic insights derived from model organism research. Alongside the cellular and invertebrate evidence, the review integrates findings from the human exercise physiology and heat acclimation literature, which provide essential empirical grounding for translating molecular mechanisms into quantitative protocol parameters and for distinguishing effects confirmed in human tissues from those inferred from model organisms alone. By integrating these domains — and situating the resulting synthesis within the broader geroscience intervention landscape — the review aims to offer a comprehensive and timely account of where the science stands, and where its most consequential uncertainties remain.

2. Methodology

The literature underpinning this review was identified and assembled through a structured search of the OpenAlex database, combining direct keyword querying with a citation network expansion protocol. The search was designed to capture the breadth of scholarship connecting heat exposure and longevity, from epidemiological evidence on sauna use to the molecular biology of hormetic stress responses.

Search Strategy

The search strategy employed five distinct keyword queries submitted to OpenAlex, each targeting a specific conceptual dimension of the topic. These queries focused on: the molecular pathways linking heat exposure to longevity and hormesis [17, 23, 18]; epidemiological and cohort-level evidence on sauna use and mortality [3, 8, 5]; the specific roles of heat shock proteins (HSP70 and HSP90) in cellular maintenance [25, 10, 12]; dose-response relationships in thermotherapy protocols [26, 27]; and emerging work on heat acclimation as a hormetic intervention [28, 29, 30]. The search emphasized recent publications from 2025 and 2026. Collectively, these queries returned 119 candidate papers, of which 30 met a relevance score threshold of 0.6 or above and were carried forward into the corpus.

Following the initial keyword search, a citation network expansion was initiated. This stage examined both forward and backward citations, ultimately adding 92 further relevant papers while rejecting 120. The expansion process was terminated once the collection reached its pre-specified target—a pool sufficient to yield 30 final papers. The coverage delta of 0.43 recorded at the conclusion of Stage 1 reflects meaningful but not exhaustive saturation of the citation neighbourhood, an expected outcome given the defined collection ceiling.

Supplementary Literature Bases

To strengthen the review’s treatment of exercise physiology, heat acclimation kinetics, and thermoregulatory adaptation in humans — domains essential for translating molecular and model organism findings into quantitative protocol guidance — a supplementary targeted search was conducted across the same database. This supplementary search prioritised primary research and authoritative reviews addressing physiological adaptation to repeated heat exposure [27], cellular and molecular responses to exercise-induced and passive hyperthermia [30, 31], and cardiovascular or autonomic effects of structured heat protocols [26, 2]. Inclusion was restricted to human populations. The search yielded an additional twelve papers spanning publication years 2005 to 2025, which were integrated into the relevant thematic sections of the review. These papers addressed gaps in the core corpus, particularly concerning acclimation timelines, HSP induction kinetics in human tissues [28], decay and re-induction dynamics [29], and clinical comparisons between passive and active heat modalities.

A second supplementary search was conducted to situate the review’s findings within the broader geroscience intervention landscape. This search targeted literature on pharmacological and behavioural interventions that engage the same molecular pathways activated by heat exposure. Specifically, it focused on the hallmarks-of-aging framework [32, 19], mTOR inhibition and autophagy induction [33, 34], NAD⁺ metabolism and sirtuin biology [35], cellular senescence and senotherapeutics [36, 37], and caloric restriction mimetics [38, 39]. This search yielded fifteen additional papers published between 2007 and 2025, which were integrated primarily into the Discussion section. These papers provide comparative mechanistic context for evaluating heat exposure alongside established geroscience interventions.

Selection and Filtering

Quality filters were applied uniformly across the candidate pool. Papers published outside a two-year recency window were required to have accumulated at least five citations, ensuring that older work retained in the corpus had demonstrated some degree of scholarly uptake. This approach reflects established practice in evidence synthesis, where citation-based signals serve as proxies for community validation of foundational findings — particularly relevant given the breadth of the heat exposure and longevity literature, which spans seminal cellular stress work [18, 17] through to recent sauna cohort studies [1, 8]. To counterbalance this criterion and preserve currency, a recency quota stipulated that at least 35% of the final corpus derive from recent literature. The relevance threshold of 0.6 was maintained throughout, functioning as a consistent minimum for inclusion rather than a post-hoc adjustment.

Four papers initially selected could not be incorporated in their original form: one failed at the acquisition stage and three were affected by marker errors. In each case, a replacement was drawn from the ranked candidate pool, preserving the intended corpus size of 30 papers without relaxing inclusion criteria.

Processing

All 30 papers in the core corpus underwent full-text analysis; no papers were processed from abstracts or metadata alone, and there were no unresolved retrieval failures at the processing stage. The combined corpus, including supplementary papers, spans publications from 2003 to 2025, reflecting both the foundational mechanistic literature on heat shock protein biology — including early work on hormetic heat stress responses [17], heat shock factor regulation [11, 18], and HSP therapeutic targets [40] — and more recent translational and epidemiological contributions examining sauna exposure in relation to cardiovascular mortality [3, 7] and all-cause mortality risk [8, 5]. The epidemiological literature notably includes prospective cohort data spanning up to 15 years of follow-up [3], while the mechanistic literature extends from cellular stress response deterioration in ageing [18] to dose-response relationships between heat exposure frequency and longevity-associated outcomes.

Thematic Organisation

The reviewed literature was organised into six thematic clusters, allowing the review to move coherently across levels of analysis—from cellular and molecular mechanisms through to population-level health outcomes. This structure accommodates the inherently multi-scalar nature of the topic, in which bench-level findings on proteostasis and stress signalling [18, 9] must be contextualised alongside clinical and epidemiological data on thermal interventions and ageing biomarkers [3, 5]. The field spans from the regulation of heat shock factors and their downstream transcriptional programmes [11, 12] to the hormetic effects of repeated mild heat stress on cellular longevity [17], necessitating an organisational framework capable of bridging these levels. The clustering approach was applied to the full corpus and provides the organisational backbone for the synthesis presented in subsequent sections. Taken together, the six clusters are designed to address the review’s four guiding research questions in an integrated and progressive fashion: questions concerning molecular pathways and HSP contributions are addressed primarily within the mechanistic clusters, while questions concerning epidemiological evidence and effective protocols are anchored in the population-level and translational clusters [8, 2]. This alignment ensures that the thematic structure does not merely organise the literature but actively serves the explanatory and evaluative aims that motivated the review.

3. Sauna and Passive Heat Therapy: Epidemiology, Cardiovascular Health, and Clinical Applications

The past decade has witnessed a remarkable consolidation of evidence positioning sauna bathing and related passive heat therapies as clinically meaningful interventions for cardiovascular protection, cognitive health, and longevity. What began as epidemiological observations in Finnish cohort studies has since evolved into a mechanistically grounded research programme, encompassing meta-analyses of vascular outcomes, experimental dissection of shear stress pathways, and targeted investigations of high-risk occupational populations. Taken together, this literature suggests that passive heat therapy occupies a genuinely distinctive niche in preventive medicine — one that may function as an exercise mimetic for populations who cannot or do not engage in vigorous physical activity, and as a resilience strategy in the context of a warming climate.

Prospective Cohort Evidence: Dose-Response Relationships and Mortality

The epidemiological foundation for this field rests substantially on Finnish prospective cohorts, which offer the statistical power and ecological validity that controlled trials of heat exposure rarely achieve. Foundational work on dementia risk [4] demonstrated that among 2,315 Finnish men aged 42–60 followed over two decades, those bathing in a sauna four to seven times weekly exhibited a 66% reduction in dementia risk relative to once-weekly users. This gradient remained robust to multivariable adjustment, immediately raising questions about whether the association captured a broader systemic neuroprotective effect or acted through cardiovascular pathways.

This question was substantially answered when cardiovascular-specific mortality data were analysed in a prospective cohort of 1,688 participants followed for 15 years. Individuals using the sauna four to seven times weekly experienced 2.7 cardiovascular deaths per 1,000 person-years compared with 10.1 in the once-weekly group, translating to a 64% reduction in risk after adjustment for established cardiovascular risk factors (hazard ratio 0.36) [3]. These findings are notable not merely for their magnitude but for their dose-response architecture: each increment of weekly sauna frequency carried independent mortality benefit, a pattern characteristic of causal biological relationships rather than confounding by health-seeking behaviour.

Systematic synthesis of this cohort evidence, alongside experimental and mechanistic data, confirmed that the benefits extended beyond cardiovascular mortality to encompass sudden cardiac death, stroke, hypertension, and pulmonary conditions [1]. The stroke risk reduction has since been quantified independently in a dedicated prospective cohort study of Finnish men and women, which found that frequent sauna use was associated with a significantly lower risk of fatal and non-fatal stroke events [6].

Crucially, the physiological responses elicited by repeated sauna sessions — including sustained elevations in heart rate and altered circulatory dynamics — were noted to parallel those of moderate-to-high-intensity physical exercise [2]. This observation raised the conceptually important hypothesis that sauna use might serve as an exercise surrogate. Subsequent work developed this hypothesis more fully [41], framing repeated sauna exposure as a hormetic stressor capable of optimising adaptive stress-response pathways, including the heat shock protein system.

Mechanistic evidence supports this framing: repeated mild heat stress has been shown to stimulate heat shock protein synthesis and proteasomal activity — via HSF1 trimerisation and activation of downstream chaperone families including HSP70 and HSP90 — without inducing cellular damage. This process thereby reduces the accumulation of oxidatively damaged proteins that characterises cellular ageing [17].

Empirical Grounding of the Exercise-Mimetic Hypothesis

The characterization of passive heat therapy as an exercise mimetic has received substantial empirical support from human exercise physiology and heat acclimation research. Controlled acclimation studies demonstrate that approximately 75–80% of cardiovascular adaptations — including reductions in exercising heart rate and expansions in plasma volume — occur within the first four to seven days of repeated heat exposure [27]. This timeline aligns with the rapid physiological benefits reported in sauna cohort studies.

Crucially, research comparing active and passive heat modalities has established that core temperature elevation, rather than mechanical exercise itself, serves as the primary driver of HSP70 upregulation in human tissues. An eleven-day controlled hyperthermia protocol elevated baseline intracellular Hsp72 in leukocytes regardless of whether the thermal stimulus was exercise-induced or passively administered [30]. This finding provides a molecular basis for the exercise-mimetic hypothesis, demonstrating that the chaperone-mediated cytoprotective response — the same pathway implicated in the anti-inflammatory and proteostatic benefits discussed in subsequent sections — can be fully engaged by thermal stress alone.

Mechanistically, heat-induced HSP90 upregulation stabilizes endothelial nitric oxide synthase (eNOS) through calcium-calmodulin signaling and Akt phosphorylation, while HSP70 suppresses NF-κB activation and reduces pro-inflammatory cytokines including TNFα and IL-6. These mechanisms link the chaperone response directly to vascular and inflammatory endpoints [31].

Furthermore, passive heat acclimation improves skeletal muscle contractility in the absence of any exercise stimulus. An eleven-day protocol of daily exposure at 48–50°C produced approximately 9% increases in evoked peak twitch amplitude and 17% improvements in maximal voluntary torque [42]. The fact that neuromuscular gains arise from temperature alone, decoupled from training-induced muscle adaptation, expands the scope of the exercise-mimetic claim beyond cardiovascular and molecular endpoints to encompass peripheral contractile function.

These findings help resolve a key interpretive challenge in the epidemiological literature: whether the benefits of habitual sauna use are attributable to thermal stress itself or to the physical exertion sometimes associated with sauna attendance. The molecular evidence strongly favors the former interpretation. Meanwhile, the overlap with exercise-induced adaptations — plasma volume expansion, heart rate reduction, and HSP induction — explains why the physiological profiles of habitual sauna users resemble those of moderately trained individuals.

Corroborating this equivalence, a 12-week controlled trial comparing hot-water immersion to high-intensity interval training found that both modalities produced clinically comparable reductions in resting systolic blood pressure (−9 mmHg and −7 mmHg, respectively). Heat therapy achieved these gains at substantially lower myocardial oxygen demand — a finding that further substantiates the exercise-mimetic framing while underscoring its particular value for populations with limited exercise capacity [43].

Cardiovascular Mechanisms: Shear Stress, Nitric Oxide, and Heat Shock Proteins

Understanding why passive heat therapy confers vascular protection has required careful mechanistic investigation. A pivotal contribution came from experimental studies demonstrating that heat therapy selectively increases anterograde shear stress while reducing retrograde and oscillatory shear in conduit vessels. Importantly, arterial adaptation is abrogated when anterograde shear is mechanically restricted [31]. This shear-stress profile represents precisely the haemodynamic stimulus recognised as pro-adaptive for endothelial function, explaining the macrovascular improvements documented across interventional studies. Heat therapy also upregulates heat shock proteins HSP70 and HSP90; the latter plays a particularly direct role in cardiovascular protection through its stabilisation and activation of endothelial nitric oxide synthase (eNOS), thereby enhancing nitric oxide bioavailability and supporting vasodilatory capacity [31]. Corroborating this mechanism, repeated sauna therapy has been shown to increase aortic eNOS mRNA and protein expression — localised specifically to endothelial cells — and to elevate serum nitrate concentrations as a marker of nitric oxide production, even reversing the progressive eNOS downregulation observed in cardiomyopathic disease models [44]. This HSP-eNOS axis, operating in concert with shear-mediated transcriptional upregulation of eNOS, provides a molecular bridge between the systemic thermal stimulus and the arterial wall adaptations observed clinically.

The haemodynamic mechanisms underlying these adaptations are further illuminated by experimental work demonstrating that combined heat stress and dehydration amplify cardiovascular strain in an additive, dose-dependent manner. Aldosterone has been identified as a central hormonal mediator of the plasma volume expansion that underpins longer-term cardiovascular conditioning [45]. This finding establishes an important principle for clinical protocol design: the cumulative magnitude of thermal perturbation — modifiable through temperature, duration, and hydration status — drives the cardiovascular adaptive signal, providing a quantitative framework for titrating therapeutic intensity to individual patient tolerance.

These mechanisms translate into measurable improvements in population-level vascular outcomes. A systematic review and meta-analysis of 15 intervention studies confirmed that heat therapy reduces mean arterial, systolic, and diastolic blood pressure in both healthy and clinical populations, while simultaneously improving macrovascular function as indexed by flow-mediated dilatation of the brachial artery [46]. These meta-analytic findings are corroborated by head-to-head clinical comparisons. A twelve-week randomised study in patients with severe lower-limb osteoarthritis — a population for whom conventional lower-limb exercise is substantially limited — demonstrated that hot-water immersion produced rapid systolic blood pressure reductions of 10–12 mmHg within ten minutes of exposure, with sustained adaptive effects of approximately 9 mmHg systolic and 4 mmHg diastolic at twelve weeks [43]. These reductions were broadly comparable to those achieved by upper-limb high-intensity interval training in the same trial (7 mmHg systolic, 3 mmHg diastolic), and fall within the range attributed to some pharmacological antihypertensive agents [43]. Notably, heated water-based exercise training has also been shown to reduce 24-hour ambulatory blood pressure in patients with resistant hypertension [47], reinforcing the clinical translatability of thermally mediated antihypertensive effects across populations with differing levels of cardiovascular compromise. That a passive thermal intervention matched the antihypertensive efficacy of structured vigorous exercise in a clinically compromised population provides direct clinical evidence for the exercise-mimetic properties of heat therapy inferred from molecular and epidemiological data. Reviewing the broader landscape of passive heat modalities — including Finnish saunas, hot-water immersion, and water-perfused suits — recent work has emphasised that habitual exposure consistently associates with reduced cardiovascular mortality, lower sudden cardiac death risk, and reduced all-cause mortality, with dose-response relationships maintained across populations and modalities [26].

However, the additive effects of combined thermal and physiological stressors warrant careful attention in clinical protocol design. While superimposed dehydration may enhance adaptive signalling in healthy individuals, it simultaneously elevates cardiovascular and thermoregulatory strain [45], an effect that may be poorly tolerated in frailer or older populations. This tension underscores the necessity of hydration management and individualised protocol titration when passive heat therapy is applied to clinical groups.

High-Risk and Occupational Populations

Translational research has proven particularly productive in applying sauna evidence to occupationally exposed populations. A mechanistic review focusing on firefighters and military personnel demonstrated that these groups face compounded cardiovascular risks from chronic physiological stress, disrupted sleep, and repeated acute haemodynamic challenges [48]. This review synthesized evidence showing that regular sauna bathing reduces cardiovascular mortality in a dose-dependent manner — with up to 50% mortality reduction among habitual users — and identified nitric oxide-mediated improvements in blood pressure, arterial stiffness, and endothelial function as the most likely mediators of this benefit in high-stress occupational contexts [48].

The mechanistic basis for these vascular benefits is well-established: repeated sauna exposure upregulates arterial endothelial nitric oxide synthase (eNOS) expression and enhances nitric oxide bioavailability [44], while acute sessions improve flow-mediated dilation as an index of endothelial responsiveness [49]. Broader mechanistic reviews confirm that passive heat therapy recapitulates many of the haemodynamic and vascular adaptations associated with aerobic exercise training, including reductions in arterial stiffness and improvements in cardiac output [31].

For populations whose occupational demands may prevent consistent aerobic exercise adherence, or who face occupational heat acclimatisation demands of their own, the exercise-mimetic properties of sauna use have particular practical relevance. This parallel is supported by direct comparisons showing that repeated passive heat exposure produces cardiovascular adaptations comparable to structured exercise interventions [43].

Broader Clinical Applications: Musculoskeletal and Neurological Rehabilitation

The therapeutic reach of water-based heat therapy extends beyond cardiovascular endpoints to encompass musculoskeletal and neurological rehabilitation. A 2025 narrative review synthesizing evidence across these conditions documented that hydrotherapy — which includes hot-water immersion, heated pool exercise, and related modalities — improves pain, range of motion, and functional recovery in osteoarthritis, fibromyalgia, and post-stroke rehabilitation through combined thermal, buoyancy, and hydrostatic mechanisms [50].

In neurological populations such as those with Parkinson’s disease and multiple sclerosis, hydrotherapy appears most effective when integrated with conventional physiotherapy rather than administered in isolation. Some comparative analyses demonstrate superior outcomes to land-based exercise alone [50]. The properties of water — including resistance, thermal conductivity, and support of postural control — create conditions uniquely suited to neuromotor retraining that cannot be fully replicated by thermal exposure on land. Specifically, hydrostatic pressure assists venous return and reduces peripheral oedema, while buoyancy unloads articular structures and lowers the muscular effort required to maintain balance. These effects facilitate movement patterns that would be biomechanically inaccessible on land [50].

Although the evidence base in emerging applications such as post-COVID-19 rehabilitation remains nascent, the rationale aligns with the broader principle that passive or partially supported thermal interventions can serve as entry-level rehabilitation tools for individuals at the lower end of the exercise tolerance spectrum [50, 26, 31]. Indeed, passive heat therapy has been specifically proposed as a viable substitute or preparatory modality for those unable to meet conventional exercise thresholds due to physical limitation or severe deconditioning [26].

Integration and Emerging Directions: Climate Resilience, Inflammaging, and Healthspan

The most recent comprehensive synthesis [51] situates passive heat therapies within a broader framework of anti-inflammatory, cytoprotective, and antioxidant physiology, presenting consistent evidence for risk reduction across hypertension, cardiovascular disease, thromboembolism, dementia, and respiratory conditions. The breadth of these benefits — spanning conditions as mechanistically diverse as atherosclerosis, neurodegeneration, and pulmonary disease — is difficult to explain through haemodynamic and proteostatic mechanisms alone and increasingly points toward the attenuation of chronic systemic inflammation as an additional mediating pathway. Ageing is now recognised to be accompanied by a state of persistent, low-grade sterile inflammation — termed inflammaging — driven by senescent cell accumulation, mitochondrial dysfunction, and dysregulated innate immune signalling [52, 36, 53]. This inflammatory state constitutes a shared pathological substrate for the very diseases against which sauna use appears protective [54, 55, 56]. Critically, this inflammatory milieu is amplified by the senescence-associated secretory phenotype (SASP), whereby senescent cells release pro-inflammatory cytokines, chemokines, and proteases that propagate tissue dysfunction across organ systems [52, 57]. As discussed in detail in Section 5, the heat shock transcription factor HSF-1, which is periodically reactivated by each sauna session, directly antagonises the NF-κB inflammatory signalling axis [58, 12], while the heat shock proteins it induces further suppress inflammatory cascades [10]. This anti-inflammatory mechanism provides a molecular explanation for why habitual heat exposure associates with reduced incidence of inflammation-driven conditions across multiple organ systems, complementing the vascular and proteostatic benefits described above. Notably, one cohort study has directly examined the relationship between sauna bathing, systemic inflammation, and all-cause mortality in Finnish men, finding that the survival benefit of frequent sauna use was partially mediated through reductions in circulating inflammatory markers [5].

Complementing this anti-inflammatory perspective, a review published in the same period specifically foregrounds passive heat therapy as a preparatory physiological strategy for populations at risk during extreme heat events — an increasingly pressing public health concern [26]. The argument is counterintuitive but evidence-based: habitual low-to-moderate heat exposure induces plasma volume expansion, reduces resting heart rate and blood pressure, and improves cardiovascular reserve [27], potentially protecting vulnerable individuals against the haemodynamic stress of environmental heat extremes [26]. These adaptations mirror those observed in formal heat acclimation protocols, in which repeated passive heat exposure has been shown to expand plasma volume by approximately 4–15%, reduce resting and exercising heart rate, and lower core temperature at equivalent workloads [27, 31].

Notwithstanding the strength of this accumulating evidence, important methodological limitations persist. The flagship Finnish cohort studies [3, 4] are observational in design and largely restricted to middle-aged men of Northern European heritage — a demographic profile that reflects the culturally distinctive nature of Finnish sauna traditions, characterised by high dry-heat temperatures of 80–100°C and lifelong habitual use [2] — thereby limiting generalisability to other populations and heat modalities. Randomised controlled trials of sufficient duration to capture clinical endpoints remain absent from the literature; most intervention studies measure surrogate outcomes over weeks to months [46, 31]. Notably, even well-designed intervention studies have revealed metabolic ceilings: the twelve-week hot-water immersion trial produced no meaningful improvements in glycaemic control despite its cardiovascular benefits [43], a finding consistent with a broader systematic review suggesting that passive heating effects on glycaemic indices are modest and population-dependent [59]. These results collectively suggest that thermal stress alone may be insufficient to address metabolic dysfunction in populations with multiple comorbidities. The optimal dose — in terms of temperature, duration, and frequency — has not been systematically optimised across different populations or heat modalities, and comparisons between Finnish dry saunas, infrared saunas, and hot-water immersion remain largely qualitative rather than head-to-head [2]. Addressing these gaps through adequately powered, diverse, and longer-term trials represents the next necessary step before passive heat therapy can be formally incorporated into clinical prevention guidelines.

4. Heat Shock Proteins: Molecular Structure, Function, and Disease Relevance

Heat shock proteins (HSPs) constitute a highly conserved superfamily of molecular chaperones whose fundamental role is to maintain protein homeostasis — protecting newly synthesised polypeptides, facilitating the refolding of stress-denatured proteins, and targeting irreparably damaged substrates for degradation [10]. Originally identified as proteins induced by thermal stress, they are now understood to operate constitutively across a broad range of cellular contexts, from mitochondrial biogenesis to immune signalling and cell death regulation. The major families — HSP90, HSP70, HSP60, and the small HSPs — differ substantially in their structural organisation and mechanistic strategies, yet collectively form an integrated proteostasis network whose dysfunction is increasingly implicated in cancer, neurodegeneration, inflammatory disease, and ageing [60, 61]. This section traces the evolution of understanding across these families, from foundational biochemical characterisation to the most recent single-molecule mechanistic revelations, and examines how this body of knowledge positions HSPs as both biomarkers and therapeutic targets.

HSP90: Architecture, Client Repertoire, and Oncological Significance

HSP90 stands as perhaps the most clinically consequential chaperone family, in part because of its extraordinary client breadth and its disproportionate abundance in malignant cells. Under basal conditions, HSP90 constitutes approximately 1–2% of total cellular protein, but in tumour cells this level rises to two- to tenfold above that observed in normal tissues [60, 10]. This overexpression is not merely quantitative but functionally significant: HSP90 stabilises a client repertoire of more than 400 proteins, including a striking concentration of oncoproteins — mutant p53, HER2, EGFR, Akt, HIF-1α, and CDK4 among them — that would otherwise be targeted for proteasomal degradation [60, 40]. By shielding these clients from quality-control pathways, HSP90 effectively buffers oncogenic mutations, permitting tumour cells to sustain levels of signalling activity that would be untenable in normal cellular contexts.

The regulatory complexity of HSP90 extends to its co-chaperone network and post-translational modification landscape. HSP90 operates through an ATP-dependent conformational cycle in which the protein transitions between open and closed dimer states, and this cycle is modulated by co-chaperones including CDC37, AHA1, and the immunophilins [60, 40]. The master stress-responsive transcription factor HSF1, which drives HSP90 expression under stress, is itself subject to phosphorylation and SUMOylation [12, 11], embedding HSP transcriptional regulation within broader cellular signalling networks and even circadian machinery [62]. These post-translational modifications govern HSF1 trimerisation, nuclear translocation, and DNA-binding competence, thereby fine-tuning the amplitude and duration of the heat shock transcriptional programme [12].

The cytosolic isoform Hsp90α warrants particular attention given its roles in regulating cell death pathways. Beyond stabilising pro-survival clients, Hsp90α influences multiple modalities of cancer cell death — modulating apoptosis through interactions with Bcl-2 family members and caspase inhibition, regulating necroptosis via stabilisation of RIPK3 and MLKL, and impacting ferroptosis through GPX4 stability and iron metabolism [63]. Overexpression of Hsp90α correlates with tumour progression, metastasis, and poorer patient outcomes across hepatocellular carcinoma, gastric cancer, and breast cancer, establishing it as both a prognostic indicator and a mechanistic driver of malignancy [63]. These findings underscore the dual therapeutic rationale for HSP90 inhibition: not only disrupting the stabilisation of oncoproteins but also potentially sensitising tumours to cell-death-inducing therapies. A cardinal therapeutic paradox complicates this strategy, however: HSP90 inhibitors display approximately 100-fold greater affinity for the activated conformer present in tumour cells compared with normal tissue, yet their administration paradoxically activates HSF-1 [12, 11], driving compensatory upregulation of HSP70 and other chaperones that may antagonise the pro-apoptotic effects of co-administered chemotherapeutic agents [40]. This compensatory feedback loop remains an active challenge for combination therapy design.

HSP70 Family: Isoform Diversity, Anti-Apoptotic Mechanisms, and Biomarker Potential

The human HSP70 family comprises at least thirteen members with distinct subcellular localisations, expression profiles, and functional specialisations [61]. The dichotomy between constitutively expressed cognate forms (HSC70/HSPA8) and stress-inducible isoforms (HSP70-1/HSPA1A, HSP70-2/HSPA1B) reflects a division of labour between housekeeping proteostasis and acute stress response, though the molecular boundaries between these roles are considerably more permeable than early classifications implied [61, 10]. The broader transcriptional regulation of stress-inducible isoforms is coordinated by heat shock factors — particularly HSF1 — which integrate signals from proteotoxic, oxidative, and metabolic stressors to calibrate family-wide expression [11].

Among the most clinically significant observations is the selective membrane expression of HSP70-1 on tumour cells: more than half of patients with solid tumours display a membrane-positive phenotype for this isoform, whereas corresponding normal tissues are membrane-negative [61]. This differential localisation has both diagnostic and therapeutic implications, providing a tumour-selective surface marker that has been exploited in natural killer cell-based immunotherapeutic strategies [61, 40]. The anti-apoptotic functions of HSP70 family members are well established — acting at multiple nodes including inhibition of cytochrome c release, direct interaction with Apaf-1 to prevent apoptosome assembly, and suppression of AIF translocation — mechanisms that collectively explain the survival advantage conferred on HSP70-overexpressing tumour cells [61, 10, 64]. These cytoprotective mechanisms are also closely integrated with autophagy regulation, as HSP70 facilitates chaperone-mediated autophagy to clear damaged proteins that would otherwise trigger cell death cascades [64].

The reconceptualisation of HSP70 as an active regulatory hub — rather than a passive chaperone — has been reinforced by recent work demonstrating that heat acclimatisation upregulates HSP70 in a brain-region-specific manner, with expression patterns correlating directly with heat resistance and cognitive protection [65]. This work positions HSP70 not merely as a chaperone but as a coordinator of autophagy flux, apoptotic signalling, and neuroinflammatory tone, arguing that the molecule’s cytoprotective effects are inseparable from its capacity to modulate these downstream pathways simultaneously [65]. This integrative view marks a departure from single-pathway models and aligns HSP70 biology with broader network-level theories of cellular homeostasis [18].

An intriguing dimension of HSP70 biology concerns its relationship with ageing and systemic inflammation. Circulating HSP70 levels decline with advancing age and correlate negatively with pro-inflammatory cytokines, positioning this chaperone as a sensitive indicator of immunological fitness and a potential longevity biomarker [61, 25]. Genetic studies have further implicated HSPA1A and HSPA1B polymorphisms in human longevity, suggesting that inter-individual variation in HSP70 inducibility may partly determine healthspan trajectories [25]. This inverse relationship between HSP70 abundance and inflammatory status suggests that the protein may play an immunomodulatory role in the extracellular compartment that is distinct from its intracellular chaperone function [61], a conceptual extension that has gained traction in subsequent literature and that situates circulating HSP70 among a growing panel of candidate inflammageing biomarkers [56].

HSP60 and Mitochondrial Protein Quality Control

HSP60 (HSPD1), a member of the chaperonin family, occupies a structurally and functionally distinct niche within the HSP universe. Unlike the HSP90 and HSP70 families, which operate as flexible scaffolds, HSP60 forms large barrel-shaped oligomeric assemblies — specifically double heptameric rings — that encapsulate substrate proteins within a protected folding chamber [66]. This architecture enables iterative, ATP-dependent folding cycles for newly synthesised and stress-denatured proteins, particularly within the mitochondrial matrix where approximately 80–85% of cellular HSP60 is resident [10]. Its co-chaperone HSP10 (the bacterial orthologue of GroES) seals the folding chamber and coordinates the ATPase cycle, a functional partnership that is essential for mitochondrial proteostasis [66, 10].

Beyond its canonical folding role, HSP60 has emerged as a pleiotropic regulator of apoptosis and inflammatory signalling. Within mitochondria, HSP60 regulates the stability of pro-apoptotic factors; paradoxically, cytosolic and extracellular HSP60 can activate innate immune signalling through pattern recognition receptors — including TLR2 and TLR4, driving NF-κB activation — contributing to sterile inflammation in conditions ranging from atherosclerosis to autoimmune disease [67, 58]. Notably, HSP60 peptides share epitopes with mycobacterial HSP65, eliciting autoimmune T-cell responses implicated in rheumatoid arthritis and lupus [10]. The dual — and sometimes opposing — roles of HSP60 in apoptosis regulation (cytoprotective in some contexts, pro-apoptotic in others) reflect the context-dependence that characterises much of HSP biology and complicates straightforward therapeutic targeting [58].

Biophysical Mechanisms: Entropic Pulling and ATP-Driven Conformational Change

Perhaps the most conceptually significant recent advance in understanding HSP chaperone mechanisms comes from single-molecule experimentation resolving a long-standing debate about how HSP70 chaperones facilitate protein translocation and unfolding. Two competing models — the Power Stroke, invoking ATP hydrolysis-driven conformational changes that physically pull substrates, and Entropic Pulling, proposing that chaperone binding generates a thermodynamic driving force without requiring mechanical work — have each attracted experimental and theoretical support [68]. HSP70s are ATP-driven molecular chaperones that alternate between ATP-bound open and ADP-bound closed conformations of their substrate-binding domain, with co-chaperones including HSP40/JDP family members and nucleotide exchange factors (NEFs) governing the chaperone cycle [61]; it is within this allosteric framework that the two models have been contested. Using a nanopore-based single-molecule system with engineered protein constructs, 2024 work demonstrated directly that DnaK binding reduces the escape energy barrier by approximately 11.5 k_B T (46 pN nm) — an effect comparable in magnitude to other molecular motors — and critically showed that this pulling effect is size-dependent and does not require ATP hydrolysis or large-scale conformational transitions, providing strong evidence against the Power Stroke model and in favour of Entropic Pulling as the operative mechanism [68]. This finding reframes how the energetics of chaperone-assisted translocation should be understood and has implications for modelling co-translational folding and protein import into organelles, including the mitochondria-resident HSP70 (Hsp70-9) and ER-resident BiP (Hsp70-5), both of which drive import through translocon-associated pulling at the membrane [61].

HSPs as Immunomodulatory Molecules and Diagnostic Biomarkers

The discovery that HSPs are released into the extracellular environment — both passively during cellular stress and actively through unconventional secretory pathways — has transformed their conceptualisation from purely intracellular chaperones to immunological effectors. Extracellular HSPs can present peptide antigens to immune cells, activate dendritic cells and macrophages via toll-like receptors, and modulate cytokine production, functions that bridge stress physiology and adaptive immunity [10, 61, 58]. These immunological activities have prompted interest in HSPs as cancer vaccine adjuvants and as targets for antibody-based therapies [40], particularly given the accessible membrane expression of HSP70-1 on tumour cells — a feature largely absent from non-transformed cells — which renders it a tractable surface target for immune-mediated killing [61].

The biomarker utility of HSPs extends beyond oncology to encompass metabolic and stress-related conditions. Comprehensive synthesis of human evidence demonstrates that HSP70 and HSP90 are measurable sentinels of cellular stress states, elevated in conditions including early-stage type 1 diabetes and renal disease, and measurable through non-invasive matrices including saliva alongside conventional plasma sampling [69]. The cellular stress response more broadly has been implicated in the pathogenesis of type 2 diabetes as well, where impaired HSP induction contributes to insulin resistance and glucotoxicity [70], further extending the diagnostic and mechanistic relevance of HSP measurement across the metabolic disease spectrum. However, as discussed in detail in Section 7, the interpretation of circulating HSP levels as biomarkers is substantially complicated by acclimation status: in heat-adapted individuals, attenuated plasma HSP72 responses to a standardised thermal challenge may reflect successful hormetic adaptation rather than absence of stress [30], underscoring the need to contextualise HSP measurements against the individual’s thermal exposure history when applying them diagnostically.

Collectively, the literature reviewed here reveals a field that has progressively deepened its mechanistic resolution — from identifying HSP families and their gross functions, through elucidating client interactions and co-chaperone networks, to resolving single-molecule biophysics — while simultaneously expanding the catalogue of disease contexts in which HSPs play substantive roles [60, 10, 66, 63, 61, 68]. The challenge ahead lies in translating this mechanistic richness into therapeutic strategies that achieve selectivity — distinguishing oncogenic HSP activity from the essential proteostatic functions upon which all cells depend [40, 60].

Yet a full account of HSP biology cannot rest at the level of protein function alone. The remarkable inducibility of HSPs in response to thermal and other proteotoxic stresses — and the precision with which their expression is calibrated to the severity and duration of that stress — implies an equally sophisticated layer of transcriptional control. Understanding how cells detect stress signals and convert them into coordinated HSP gene expression is therefore the logical next step, and it is here that Heat Shock Factor 1 (HSF-1) assumes centre stage. As the master transcriptional orchestrator of the heat shock response, HSF-1 not only determines when and to what degree HSPs are produced, but also integrates inputs from metabolic, inflammatory, and longevity pathways in ways that extend far beyond a simple emergency response — a complexity that the following section examines in detail.

5. Heat Shock Factor 1 (HSF-1) and Transcriptional Regulation of the Stress Response

Heat Shock Factor 1 (HSF-1) emerged from early biochemical work as the primary transcriptional activator of heat shock protein (HSP) genes, yet decades of investigation have progressively revealed it to be far more than a simple emergency switch. It is now understood as a versatile integrator of stress signaling, developmental cues, metabolic status, and longevity pathways. Tracing the evolution of this understanding—from early models of chaperone-mediated repression to contemporary genomic mapping of thousands of target genes—illuminates how the field has continually expanded its conception of what HSF-1 does and how it is controlled.

Activation Mechanisms: Beyond a Simple Thermometer

Early models of HSF-1 activation centered on the monomer-to-trimer transition: under non-stress conditions, HSF-1 is held in an inactive monomeric state through association with chaperones such as HSP90, HSP70, and HSP40, which are titrated away when misfolded proteins accumulate during proteotoxic stress [12, 11]. In this feedback scheme, chaperones act as both suppressors of HSF-1 and first responders to unfolded client proteins, meaning that any proteotoxic insult—thermal, chemical, or age-related—can in principle engage the same activating logic [9, 16]. This chaperone displacement model established the core feedback control logic of the heat shock response, but subsequent work identified additional sensory layers that operate in parallel. A key refinement was the discovery of the RNA thermometer HSR-1 in C. elegans, which undergoes a conformational change at elevated temperatures and collaborates with the RNA-binding protein MSI-2 to facilitate HSF-1 activation [12]. This finding introduced a post-transcriptional dimension to stress sensing that the chaperone model alone could not explain. Equally significant was the identification of intrinsic redox sensing: HSF-1 can form intermolecular disulfide bonds under oxidative conditions, providing a direct molecular mechanism by which oxidative and thermal stress converge on the same transcription factor [12, 18]. A further layer of complexity emerged from C. elegans genetics, where neuronal circuits were shown to regulate the heat shock response non-cell-autonomously, indicating that organismal stress sensing involves systemic coordination beyond cell-autonomous chaperone dynamics [12, 9, 23]. Together, these findings reframed HSF-1 activation as a multi-input coincidence detector rather than a single-threshold thermostat [14, 11].

Post-Translational Regulation: Phosphorylation, SUMOylation, and Acetylation

Considerable effort has been devoted to deciphering how post-translational modifications (PTMs) tune HSF-1 activity after it has been activated. Phosphorylation was the first PTM recognized, with hyperphosphorylation accompanying transcriptional activation; however, the picture is complex because specific phosphorylation events can be either activating or repressive depending on the residue and context [12, 11]. A conceptually important advance was the identification of the phosphorylation-dependent SUMOylation motif (PDSM) in HSF-1, wherein phosphorylation at a priming site potentiates SUMO conjugation at an adjacent lysine, coupling these two modifications in a coordinated manner that dampens transcriptional output [12]. SUMOylation thus functions as a brake on prolonged HSF-1 activation, preventing maladaptive or constitutive stress responses. The role of acetylation added yet another regulatory dimension: acetylation of a critical lysine residue in the HSF-1 DNA-binding domain disrupts DNA binding and attenuates transcription, while the NAD⁺-dependent deacetylase SIRT1 counteracts this modification to maintain HSF-1 in a DNA-binding competent state [11]. The SIRT1–HSF-1 axis is particularly noteworthy because it links the heat shock response to cellular metabolic status and connects stress biology to the broader biology of aging. Because sirtuin enzymatic activity is obligatorily coupled to NAD⁺ as a cofactor, SIRT1 functions as a direct sensor of the cell’s energy and redox state [35], with activity rising under caloric restriction — conditions that elevate NAD⁺ availability [35] — and declining with age as NAD⁺ levels fall across tissues. This places HSF-1 transcriptional competence under the direct influence of systemic metabolic state, integrating proteostatic stress signaling with the core nutrient-sensing machinery that governs longevity.

HSF Family Diversity and Functional Interplay

While HSF-1 is the dominant stress-responsive factor in vertebrates and nematodes, the existence of a multi-member HSF family introduces regulatory complexity through inter-paralog cooperation and competition. Mammals encode HSF1, HSF2, HSF3, and HSF4, each with partially distinct expression patterns and biological roles [11]. HSF1 itself is normally held in an inactive monomeric state and must trimerize to bind DNA and activate transcription upon stress [12]. HSF2 lacks robust stress-inducibility on its own but physically interacts with HSF1 and modulates its binding at co-occupied target loci, suggesting that heterotrimeric complexes shape the precise transcriptional output of the stress response [11, 12]. HSF4 plays roles in sensory organ development — including lens and olfactory epithelium differentiation — and lacks the transactivation domains characteristic of stress-responsive family members, illustrating that the HSF scaffold has been repurposed across evolution for developmental gene regulation far removed from proteostasis [11]. The broader review of HSF functions across species reinforced the view that even the most conserved stress pathway has been elaborated into a multi-factor network capable of integrating diverse biological signals, from proteotoxic stress to metabolic state and developmental cues [71, 12].

HSF-1, DAF-16/FOXO, and the Insulin/IGF-1 Longevity Pathway

One of the most consequential discoveries concerning HSF-1 function beyond classical stress biology was its role as a longevity determinant in C. elegans [72]. Landmark genetic experiments demonstrated that overexpression of HSF-1 extends lifespan by approximately 40% and enhances resistance to multiple stressors, while HSF-1 knockdown via RNAi suppresses the longevity conferred by reduced insulin/IGF-1 signaling through the daf-2 pathway [72]. Crucially, HSF-1 and DAF-16/FOXO, the canonical transcriptional effector of the insulin/IGF-1 pathway, act in parallel and partially overlapping ways to extend lifespan, with each factor activating distinct but complementary downstream targets including small heat shock proteins such as HSP16 family members [72]. This functional convergence established HSF-1 as an integral component of the proteostasis network that governs healthy aging [14].

The systems-level perspective elaborated subsequently emphasized that HSF-1 activity declines sharply in early adulthood in C. elegans, a trajectory that correlates with the well-documented collapse of protein homeostasis capacity at reproductive maturity [24]. Critically, this collapse is not gradual but represents a discrete early molecular event: using temperature-sensitive misfolding-sensor proteins across multiple tissues, Ben-Zvi et al. demonstrated that proteostatic failure occurs between days two and seven of adulthood — well before general physiological decline — and that both the heat shock response and the unfolded protein response are significantly dampened by day four of adulthood [24]. This early tipping point results in a marked increase in susceptibility to aggregation-prone proteins [24, 9]. The cell-type specificity of this decline is notable: neurons exhibit particularly compromised heat shock responses with selective or incomplete HSF-1 activation, potentially explaining the heightened vulnerability of neural tissue to proteotoxic disease [9, 16]. The pleiotropic roles of HSF-1 in stress adaptation, development, and longevity have since been surveyed comprehensively, underscoring that its function is inseparable from the broader cellular regulatory network rather than confined to an acute stress module [71].

Genomic Mapping of HSF-1 Target Genes

A critical limitation of early work was its focus on a restricted set of canonical HSP targets, creating an incomplete picture of HSF-1’s transcriptional reach. The construction of HSF1Base addressed this gap directly by manually curating data from 117 peer-reviewed publications and high-throughput genomic datasets to compile 15,641 unique HSF-1 gene interactions, identifying 1,321 directly bound target genes of which 774 are activated and 547 are repressed [13]. This resource revealed that HSF-1 regulatory activity extends well beyond proteostasis to encompass circadian rhythm, chromatin remodeling, cell cycle control, ribosome biogenesis, and autophagy [13]. The inclusion of repressed targets is particularly significant, as earlier models had predominantly cast HSF-1 as a transcriptional activator [11, 12]; the substantial proportion of repressed genes indicates that HSF-1 reshapes the transcriptional landscape in both directions during stress, likely facilitating the global reprogramming of gene expression that allows cells to prioritize proteostatic functions [9]. Notably, this stress-induced transcriptional reprogramming is not limited to the acute heat shock response itself — in C. elegans, a distinct post-stress transcriptional program, regulated by the endoribonuclease ENDU-2, translates transient HSF-1 activation into durable improvements in lifespan and stress resistance [73]. Collectively, the genomic evidence positions HSF-1 not as a dedicated stress factor but as a broad-spectrum transcriptional regulator whose activity is continuously modulated by the PTM network described above, and whose outputs are shaped by its interactions with co-factors including DAF-16/FOXO [72] and other HSF family members [11].

HSF-1 as an Anti-Inflammatory Regulator: Crosstalk with NF-κB and Implications for Inflammaging

Among the most consequential non-canonical functions of HSF-1 — and one with direct implications for understanding how repeated heat exposure reduces age-related disease — is its capacity to suppress inflammatory signalling through direct antagonism of the NF-κB pathway. NF-κB is the master transcriptional regulator of innate and adaptive immune responses, driving expression of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α), chemokines, and adhesion molecules. Under acute conditions, NF-κB activation is adaptive and self-limiting; however, in the context of aging, NF-κB activity becomes chronically elevated, contributing to a state of persistent, low-grade sterile inflammation now widely recognised as a defining hallmark of biological aging [74]. This phenomenon — termed inflammaging — is not merely a correlate of advancing age but a central mechanistic driver of age-related cardiovascular disease, neurodegeneration, metabolic dysfunction, and cancer [54, 55]. The concept has been further refined through frameworks such as senoinflammation, which integrates oxidative stress, cellular senescence, and immune dysfunction into a unified model of age-related inflammatory dysregulation [75].

The molecular architecture of inflammaging involves multiple convergent and self-reinforcing triggers. Senescent cells, which accumulate progressively with age, secrete a complex cocktail of pro-inflammatory mediators through the senescence-associated secretory phenotype (SASP), including IL-6, IL-8, and matrix metalloproteinases, that remodel the tissue microenvironment and recruit further immune activation [55, 76, 77, 52]. Approximately forty percent of SASP factors have been shown to correlate with aging biomarkers in human populations [52], underscoring the direct epidemiological relevance of this paracrine signalling programme. The SASP is itself governed by NF-κB, mTOR signalling, and cGAS-STING pathway activation in response to cytosolic DNA damage signals [52, 78], establishing it as a dynamically regulated transcriptional programme rather than a passive consequence of cell-cycle arrest. Concurrently, mitochondrial dysfunction generates excess reactive oxygen species (ROS) that activate redox-sensitive inflammatory signalling, while impaired autophagic clearance permits accumulation of damaged organelles and misfolded proteins that serve as endogenous danger signals [55, 36, 53]. The NLRP3 inflammasome occupies a critical integrative node in this cascade, sensing mitochondrial ROS, lysosomal destabilization, and aggregated proteins to sustain caspase-1-dependent production of IL-1β and IL-18 — cytokines that further amplify the inflammatory loop [55, 77]. Dysregulation of myeloid cell function with age, including impaired macrophage phagocytosis and skewing toward pro-inflammatory polarisation states, further entrenches this chronic inflammatory milieu [57]. The result is a feed-forward system in which inflammation, oxidative damage, and proteotoxic stress become mutually reinforcing — a cycle whose molecular logic converges substantially on NF-κB as the central transcriptional amplifier [56].

Crucially, this chronic NF-κB activation does not operate in isolation from the proteostasis and autophagy systems discussed in preceding sections. Sustained NF-κB signalling suppresses autophagy through multiple mechanisms, including transcriptional upregulation of autophagy inhibitors and metabolic reprogramming that diverts cellular resources away from quality-control functions [79]. Notably, IKK-NF-κB signalling has been shown to inhibit autophagic flux while simultaneously promoting inflammatory gene expression, creating a context-dependent regulatory circuit that becomes increasingly deleterious in the aged tissue environment [79]. This creates a particularly destructive convergence: the very pathway that drives chronic inflammation simultaneously disables one of the cell’s principal mechanisms for clearing the damaged proteins, senescent organelles, and cellular debris that fuel inflammatory signalling in the first place. The oxidative stress–inflammation axis is further reinforced by antagonistic crosstalk between NF-κB and the antioxidant transcription factor Nrf2, where chronic NF-κB activation suppresses Nrf2-dependent antioxidant defences, compounding oxidative damage to proteins, lipids, and DNA [80]. Recent work has elaborated this relationship further, demonstrating that NRF2 activation follows a hormetic dose-response curve in its regulation of both redox homeostasis and proteostasis, and that its therapeutic window is bounded on both sides — insufficient activation permits accumulating damage while constitutive activation may paradoxically impair cellular fitness [81].

It is within this inflammatory landscape that the anti-inflammatory functions of HSF-1 acquire their significance for aging and longevity. Activated HSF-1 directly interacts with the NF-κB subunit RelA/p65, inhibiting NF-κB DNA binding and transcriptional activity [12, 11]. This antagonism is bidirectional: NF-κB activation can reciprocally suppress HSF-1-dependent transcription, establishing a competitive regulatory axis in which the balance between stress-protective and pro-inflammatory transcriptional programmes is determined by the relative activation state of these two factors. The downstream products of HSF-1 activation further consolidate anti-inflammatory tone: intracellular HSP70 inhibits NF-κB activation by stabilising IκBα and interfering with IKK complex activity [58, 65], while also suppressing NLRP3 inflammasome assembly — the very complex identified as a key amplifier of age-related inflammation [10, 61]. The breadth of HSF-1’s genomic regulatory reach, including the repression of hundreds of target genes identified through systematic curation [13], is consistent with a transcriptional programme that extends well beyond chaperone induction to encompass active suppression of pro-inflammatory gene networks during stress.

The significance of this HSF-1/NF-κB axis becomes especially apparent when mapped onto the temporal dynamics of aging. As organisms age, declining HSF-1 activity — documented in early adulthood in C. elegans and attributed to defects in signal transduction, reduced SIRT1 expression, and altered chromatin accessibility [9, 18] — would be expected to release NF-κB from HSF-1-mediated repression, permitting the chronic inflammatory state that characterises biological aging. The convergence on SIRT1 is particularly instructive: this NAD⁺-dependent deacetylase simultaneously maintains HSF-1 in a transcriptionally competent state through deacetylation of its DNA-binding domain [11] and directly suppresses NF-κB transcriptional activity. The age-related decline in NAD⁺ availability and SIRT1 expression — itself compounded by the metabolic reprogramming of senescent cells [36] — thus simultaneously disinhibits both inflammatory signalling and proteostatic decline, providing a molecular explanation for why these two cardinal features of aging progress in parallel rather than independently. This NAD⁺–SIRT1 nexus also positions heat exposure within the broader landscape of geroscience interventions: the same molecular node targeted by NAD⁺ precursors such as NMN and NR, which aim to restore sirtuin activity through substrate repletion [82, 20], is periodically re-engaged by each episode of thermal stress through HSF-1 reactivation, suggesting mechanistic complementarity between pharmacological and thermal approaches to sustaining the SIRT1-dependent anti-inflammatory and proteostatic programmes that erode with age.

Repeated heat exposure, by periodically reactivating HSF-1 and inducing HSP expression, may therefore counteract inflammaging through a dual mechanism: directly suppressing NF-κB transcriptional activity during and after each thermal stimulus, and indirectly reinforcing anti-inflammatory tone through sustained elevation of HSP70 and other NF-κB-inhibitory chaperones. This anti-inflammatory axis operates in parallel with, and is mechanistically complementary to, the proteostatic benefits of heat-induced chaperone expression discussed in previous sections. Notably, the geroscience literature has identified several pharmacological strategies that converge on the same inflammatory targets: rapamycin and its analogues suppress SASP output through mTORC1 inhibition, senolytic agents such as dasatinib plus quercetin directly eliminate the senescent cells that produce SASP [83, 84], and NAD⁺ precursors restore the SIRT1 activity that maintains anti-inflammatory transcriptional programmes [19, 85, 84]. That heat exposure engages this anti-inflammatory axis through a non-pharmacological, HSF-1-mediated pathway distinguishes it mechanistically from these agents while targeting the same downstream inflammatory mediators, a convergence with important implications for combinatorial intervention strategies discussed in Section 9.

Together, these two pathways — proteostasis maintenance and inflammaging attenuation — provide a comprehensive molecular framework for understanding the epidemiological associations between habitual heat exposure and reduced mortality from inflammation-driven diseases including cardiovascular disease and neurodegeneration (Section 3). The framework also suggests specific, testable predictions: individuals with higher baseline inflammatory burden or lower HSF-1 inducibility may derive proportionally greater benefit from heat therapy, while the anti-inflammatory effects should be detectable as reductions in circulating IL-6, CRP, and other inflammaging biomarkers following structured sauna protocols.

6. Proteostasis Networks, Aging, and the Decline of Cellular Quality Control

The preceding sections have examined the molecular actors at the centre of the heat stress response — HSPs, HSF-1, and their roles in chaperone induction and inflammatory suppression. The present section shifts focus from these individual components to the broader systems-level network within which they operate: the proteostasis machinery that integrates chaperone activity, protein degradation, and quality control surveillance into a coherent cellular maintenance programme. Much of the foundational evidence reviewed here derives from C. elegans, whose genetic tractability and compressed lifespan have made it an indispensable model for dissecting how proteostasis networks are organised and why they fail. The section traces a thematic arc from the surprisingly early collapse of these networks at the onset of aging, through the mechanisms underlying declining stress responses and the neuroendocrine signals that coordinate quality control across tissues, to the intersection of proteostasis with mitochondrial function and hormetic ROS signalling — collectively illuminating why aging is better understood as a regulated process of network deterioration than a passive accumulation of damage.

Proteostasis — the integrated network of molecular chaperones, the ubiquitin-proteasome system (UPS), autophagy, and the unfolded protein response (UPR) — represents one of the most fundamental axes around which cellular life is organised. Its gradual failure with age is now understood to be not merely a consequence of physiological decline but one of its earliest molecular precipitants. Research spanning the last two decades, much of it anchored in Caenorhabditis elegans as a tractable model for aging biology, has transformed our understanding of how proteostasis networks are coordinated, how they deteriorate, and how environmental and neuroendocrine signals shape their trajectory across the lifespan.

Proteostasis Collapse as an Early Driver of Aging

A foundational insight emerged from work by [24], who demonstrated that proteostasis collapse is not a late-stage epiphenomenon of aging but a surprisingly early molecular event. Using a panel of temperature-sensitive missense mutant proteins as tissue-specific folding sensors in C. elegans, Ben-Zvi and colleagues showed that multiple proteins across different tissues misfolded simultaneously between days 2 and 7 of adulthood — long before measurable physiological decline. Corroborating this, proteomics studies confirm that protein aggregation begins in early adulthood as a nonrandom process influenced by protein sequence, and stress response pathways become substantially impaired as early as day 2–3 of adulthood, preceding the broader collapse of folding capacity [14]. The synchrony of this collapse across tissues implied a systemic, rather than tissue-autonomous, failure of protein quality control machinery. This finding fundamentally reframed aging research: rather than asking which misfolded proteins accumulate over time, it became necessary to ask why the infrastructure that manages them fails so early.

This reframing was given theoretical grounding by [16], who articulated a conceptual framework for understanding why proteostasis is so inherently fragile. Proteins are, by evolutionary necessity, only marginally stable in vivo — structural flexibility required for function constrains thermodynamic stability, leaving the proteome chronically reliant on chaperone networks for proper folding. The human proteostasis network encompasses an estimated ~2,000 components — including ~330 chaperone proteins, ~850 ubiquitin-proteasome components, and ~500 autophagy-lysosomal factors — yet this system is calibrated to match misfolded protein flux rather than maintained with large excess capacity, meaning it operates close to its buffering limit under normal conditions [15]. Any perturbation — whether from aging, mutation, or environmental stress — can rapidly tip the balance toward proteotoxicity. This marginal buffering model explains why proteostasis collapse, once initiated, tends to be rapid and systemic rather than gradual and localised [14].

Declining Stress Responses: Heat Shock, UPS, and Beyond

Central to proteostasis maintenance is the heat shock response, orchestrated primarily by the transcription factor HSF-1. [9] synthesised evidence showing that HSF-1 activity declines sharply in early adulthood in C. elegans, with neurons exhibiting a particularly compromised response — selective or incomplete HSF-1 activation compared to other cell types. Crucially, this collapse is not gradual: [24] demonstrated that proteostatic capacity becomes critically limiting between days two and seven of adulthood, well before other recognised markers of physiological decline — a tipping point at which both the heat shock response and the unfolded protein response are substantially dampened. This neuron-specific vulnerability is notable given the long-lived nature of post-mitotic neurons and their dependence on sustained proteostasis across decades of life in higher organisms [14].

The broader landscape of stress response deterioration with age was comprehensively mapped by [18], who synthesised evidence across multiple model organisms including yeast, nematodes, and flies. Their analysis identified several mechanisms underlying the age-related decline in heat shock response inducibility: defects in HSF-1 signal transduction, declining SIRT1 expression (which normally facilitates HSF-1 activation through deacetylation [12]), and paradoxically elevated basal HSP expression that appears to reflect chronic proteotoxic load rather than robust adaptive capacity. The UPS shows a parallel deterioration with age, driven by decreased proteasomal subunit expression, increased oxidative modification of proteasome components, and direct inhibition by aggregated or damaged proteins that obstruct the proteasomal barrel [18, 86, 87]. Together, these mechanisms create a self-reinforcing cycle: declining clearance capacity leads to accumulation of misfolded and oxidatively damaged proteins, which further impair the very systems responsible for their disposal.

Cell-Nonautonomous Regulation and Neuroendocrine Coordination

One of the most conceptually significant developments in proteostasis biology has been the recognition that protein quality control is not solely a cell-intrinsic matter but is coordinated across tissues through neuroendocrine signalling. [23] reviewed evidence that thermosensory neurons in C. elegans non-autonomously regulate the heat shock response, with the nervous system capable of distinguishing between acute heat stress and chronic protein misfolding to mount qualitatively different downstream responses. Temperature influences aging not merely through passive thermodynamic acceleration of protein unfolding but through genetically encoded neuronal and endocrine signalling networks that actively reset proteostatic thresholds across the organism [23]. Olfactory and chemosensory neurons have similarly been shown to extend lifespan through TGF-β signalling and unfolded protein response activation, further illustrating how sensory inputs are transduced into systemic proteostatic adjustments [88].

This systemic view integrates with findings reported by [9] that neurons, despite their limited HSF-1 activation, appear to exert disproportionate influence over organismal proteostasis through non-cell-autonomous mechanisms. The emerging picture is of a hierarchical proteostasis architecture in which the nervous system functions as a master regulator, sensing stress and broadcasting coordinating signals to peripheral tissues — a model with important implications for understanding why neurodegeneration and systemic proteostasis failure so frequently co-occur in aging [87, 14]. Indeed, the age-related collapse of proteolytic capacity — spanning both the ubiquitin-proteasome system and autophagy — is now recognised as a shared mechanistic substrate linking neuronal vulnerability to organismal proteostasis decline [87].

Temperature as an Environmental Regulator of Proteostasis and Longevity

The relationship between temperature, proteostasis, and lifespan has moved from simple thermodynamic explanation toward a more nuanced genetic and signalling framework. [23] emphasised that the well-documented inverse relationship between ambient temperature and C. elegans lifespan is mediated not simply by the kinetics of molecular damage but by temperature-sensitive neuronal circuits that engage endocrine pathways — including insulin/IGF-1-like signalling and other modulators of longevity. Within this pathway, the insulin/IGF-1 receptor DAF-2 and its downstream transcription factor DAF-16/FoxO are central effectors: HSF-1 and DAF-16 cooperate to upregulate small heat-shock proteins, and animals overexpressing hsf-1 live approximately 40% longer than wild-type controls [72]. This places temperature squarely within the domain of regulated biology, where the organism’s genetic makeup determines how environmental thermal information is transduced into proteostatic and longevity outcomes.

Mitochondrial Dysfunction, ETC Mutations, and Hormetic ROS Signalling

Mitochondrial function intersects with proteostasis networks through multiple routes, including the generation of reactive oxygen species (ROS) that can overwhelm protein quality control systems. A recent study by [89] examined the consequences of electron transport chain (ETC) mutations in C. elegans, demonstrating that these mutations recapitulate human mitochondrial disease phenotypes including lactic acidosis and muscle weakness. Counterintuitively, specific mutations in Complex I and III extend lifespan through hormetic ROS signalling — low-level mitochondrial ROS that activate stress response pathways, including proteostatic ones, rather than simply causing damage [89]. This phenomenon, termed mitohormesis, operates through retrograde ROS signalling to the nucleus, activating transcription factors including NF-κB, FOXO, HIF, and NRF2, while simultaneously engaging the mitochondrial unfolded protein response (UPR^mt) and integrated stress response to upregulate chaperones and proteases that sustain proteostasis [90]. This finding adds an important layer to the proteostasis narrative: the mitochondrial network is not merely a source of proteotoxic insult but can, under specific conditions, serve as an upstream activator of protective quality control responses [18]. The dual role of ROS — damaging at high levels, signalling at low levels — mirrors the broader logic of hormesis that underlies many aging interventions [91] and suggests that the relationship between mitochondrial dysfunction and proteostasis collapse is bidirectional and context-dependent. Integrative analyses across model organisms have reinforced this perspective, demonstrating that mitochondrial ROS damages mitochondrial DNA at approximately ten times the rate of nuclear DNA while simultaneously accelerating telomere shortening, which in turn suppresses mitochondrial biogenesis through p53-mediated repression of PGC-1α, closing a vicious cycle that makes mitochondrial decline self-perpetuating [53].

Synthesis

Across these bodies of work, a coherent picture emerges: proteostasis in C. elegans and likely in higher organisms is maintained by a tightly calibrated, organisationally hierarchical network operating with limited buffering capacity [16]. Its collapse is an early and systemic event in aging [24], driven by declining HSF-1 activity, UPS impairment, and failing sirtuin-dependent regulation [18, 9], and modulated by thermosensory and neuroendocrine signals that coordinate quality control across tissues [23]. Mitochondrial ETC function further intersects this network through hormetic ROS pathways that can either exacerbate or paradoxically extend healthspan depending on their magnitude [89]. What this literature collectively underscores is that aging is not a passive accumulation of damage but an actively regulated — and potentially modifiable — process of proteostatic network deterioration [14]. The recognition that these same proteostatic pathways are now pharmacologically targetable — through mTOR inhibitors that restore autophagic flux and extend lifespan across multiple model organisms [34, 92], NRF2 activators that coordinate redox defence with protein quality control [81], and NAD⁺ precursors that sustain sirtuin-dependent HSF-1 competence [82] — positions heat exposure as one modality within a broader toolkit of interventions converging on the proteostasis network. Heat stress carries the distinctive advantage of simultaneously engaging HSF-1-driven chaperone induction, autophagic flux, and hormetic redox signalling through a single physiological stimulus [21, 17], a degree of pathway co-activation that targeted pharmacological agents do not readily replicate.

7. Hormesis, Heat Stress, and the Biology of Stress-Induced Longevity

The principle that mild, transient stress can stimulate adaptive responses exceeding baseline capacity — hormesis — has emerged as a unifying biological framework linking cellular stress physiology to longevity, neuroplasticity, and therapeutic practice. What began as a largely pharmacological and toxicological concept has been progressively reinterpreted through molecular biology, epigenetics, and translational medicine, with heat stress serving as one of the most tractable and well-characterized hormetic stimuli. Across model organisms and human populations, the evidence now traces a coherent mechanistic arc from brief thermal perturbation to lasting improvements in cellular maintenance, stress resilience, and healthspan.

Autophagy as the Cellular Engine of Hormetic Heat Response

A foundational mechanistic question in this field concerns the cellular programs that translate mild heat shock into durable protective benefits. Early work on heat shock proteins established that transient thermal stress induces molecular chaperones that prevent proteotoxic damage [9, 12] — a response mediated through HSF-1 transitioning from an inactive monomer to active trimers that rapidly upregulate chaperone gene expression by binding conserved heat shock elements in target gene promoters [9, 11]. This activation cycle is itself subject to elaborate post-translational regulation, including phosphorylation and acetylation, with the deacetylase SIRT1 maintaining HSF-1 in a DNA-binding-competent state — a mechanism whose age-dependent decline directly links HSF regulation to deteriorating proteostasis [11]. Yet the full downstream quality-control program extended well beyond chaperone induction and remained incompletely characterized. A pivotal study by [21] brought autophagy into sharp focus as a central effector of hormetic heat shock. Using C. elegans as a genetic model, this work demonstrated that a single mild heat shock — one hour at 36°C — is sufficient to induce autophagy across multiple tissues simultaneously, including hypodermal seam cells, body-wall muscle, neurons, and intestinal cells. Critically, this response was not merely coincidental: genetic disruption of autophagy abolished the survival benefits of mild heat shock, establishing that autophagy induction is mechanistically required rather than epiphenomenal. The heat shock transcription factor HSF-1 emerged as a key upstream regulator, with HSF-1 overexpression sufficient to increase autophagosomal structures and upregulate autophagy gene expression even in the absence of external stress [21]. Complementing this HSF-1-driven axis, the transcription factor HLH-30 — the C. elegans ortholog of mammalian TFEB — also drives autophagy and lysosomal gene expression in response to stress, with its nuclear localization serving as a key convergence point for multiple longevity-promoting pathways [93]. Notably, HSF-1 activity is known to decline sharply in early adulthood in C. elegans, correlating with increased susceptibility to protein misfolding and proteostatic collapse [9, 72] — lending particular significance to interventions that re-engage this pathway. Taken together, these findings position HSF-1 not only as a proteostasis regulator through chaperone induction but as a broader coordinator of cellular quality-control programs [86, 87], integrating heat stress signals — via both chaperone networks and autophagy-lysosomal transcription factors — into a coherent longevity-promoting response.

Epigenetic and Structural Memory of Early-Life Thermal Stress

If the [21] findings explained the acute logic of hormetic heat, a subsequent and conceptually striking question was whether such stress could leave lasting — even permanent — cellular traces. The discovery that early-life thermal stress in C. elegans generates durable organismal resilience through an entirely distinct molecular pathway substantially complicated and enriched the picture [22]. Rather than operating through HSF-1 or canonical heat shock pathways — whose transcriptional regulatory logic has been extensively characterized across metazoans [11, 12] — this effect was mediated by the CBP-1 histone acetyltransferase, which drove persistent upregulation of the tetraspanin TSP-1. Tetraspanins are membrane-organizing proteins that characteristically form lateral assemblies and scaffold signaling microdomains, and TSP-1 was found to assemble into stable, high-molecular-weight multimeric web structures at the apical intestinal membrane that persisted long after the initiating stress was removed [22]. This constitutes a novel form of structural cellular memory — not encoded in gene sequence or even in transcriptional programs that require ongoing maintenance, but stabilized in the physical architecture of the membrane itself. The independence from HSF-1 is theoretically significant: it implies that early-life and adult heat responses engage at least partially non-overlapping molecular programs, with the early-life epigenetic response potentially conferring a qualitatively different and more durable form of resilience. Consistent with the broader principle that early-life environmental inputs can reprogram stress competence, related work has shown that environmental stressors in C. elegans can trigger transgenerationally heritable survival advantages through germline-to-soma signaling mechanisms [94]. Further supporting the generality of stress-induced epigenetic reprogramming, transcriptome-wide analyses have demonstrated that heat hormesis in C. elegans is accompanied by lasting reorganization of gene expression programs beyond the immediate stress response [73]. Together, these C. elegans studies [21, 22] establish a layered model in which hormetic heat operates through both acute autophagy-mediated proteostasis and epigenetically encoded structural remodeling.

Acclimation Kinetics, HSP Blunting, and the Paradox of Successful Hormetic Adaptation

The hormesis framework predicts that repeated mild stress should recalibrate cellular defences to operate at a higher baseline, but it also raises a less frequently examined corollary: if adaptation is successful, the acute stress response itself should diminish — a phenomenon that, if misinterpreted, could be taken as evidence of declining benefit rather than of enhanced resilience. Human heat acclimation studies have provided some of the clearest empirical demonstrations of this hormetic paradox. An eleven-day controlled hyperthermia protocol elevated baseline intracellular Hsp72 concentrations in leukocytes while simultaneously blunting the exercise-induced increment in both intracellular and plasma Hsp72 that would be expected in non-acclimated individuals [30]. This dissociation — higher constitutive protection paired with attenuated acute inducibility — exemplifies a hallmark of successful hormetic adaptation: the system has upregulated its baseline cytoprotective capacity to the point where the marginal stimulus of each subsequent exposure no longer exceeds the buffering threshold required to trigger a full transcriptional response. Broader molecular surveillance confirms that this blunting extends across multiple HSP family members and coincides with measurable shifts in circulating biomarkers of the heat-adapted phenotype [28].

The molecular mechanisms sustaining this elevated baseline have been illuminated by epigenetic investigations demonstrating that the heat-acclimated phenotype is stabilised through histone acetylation, chromatin remodelling, and poly(ADP-ribose)polymerase 1 (PARP-1) activity, which collectively enable constitutive upregulation of HSP70 and HSP90 expression [95]. This epigenetic encoding represents a qualitatively different form of stress memory from the tetraspanin-based structural remodelling identified in C. elegans [22]: whereas tetraspanin webs persist as physical membrane architectures, histone modifications create a transcriptional permissiveness that lowers the activation threshold for HSF-1-driven gene expression upon re-exposure. Critically, this chromatin-level memory can be rapidly re-established after a period of deacclimation, and re-acclimation proceeds approximately eight to twelve times faster than initial acclimation [29] — a ratio far exceeding what passive physiological readjustment alone could explain and strongly consistent with the persistence of epigenetic marks that prime the transcriptional machinery for rapid re-engagement [95, 29]. The cross-tolerance implications are equally significant: epigenetically primed HSP70 expression confers protection not only against subsequent thermal challenges but also against ischaemic and oxidative insults [96, 65], suggesting that the acclimation memory has therapeutic relevance beyond its original stressor context [95]. Indeed, HSP70 induction has been shown to suppress pro-apoptotic signalling and attenuate inflammatory cascades under both hypoxic and reactive-oxygen-species-mediated injury conditions [65], further substantiating the mechanistic breadth of cross-tolerance.

These findings complicate the practical application of hormetic heat protocols in an important way. If successful acclimation blunts the very HSP induction that is hypothesised to mediate long-term benefit, then sustained protective effects may require either progressive dose escalation — higher temperatures or longer durations to continue exceeding the rising adaptive threshold [27] — or periodic deacclimation intervals that allow baseline cytoprotective capacity to partially decay before re-engagement. The decay kinetics documented by [29] indicate that heat acclimation adaptations begin to decay within one to two weeks of cessation, with most physiological gains substantially diminished by three to four weeks, suggesting that a two-to-three-week withdrawal period followed by brief re-acclimation may represent an efficient strategy for periodically re-stimulating the full hormetic response without sacrificing the constitutive baseline protection. This periodisation logic, well established in exercise training science [27], has not yet been systematically applied to heat therapy protocols, and its empirical validation represents a priority for translational research.

Hormesis as a Unifying Framework for Neuroplasticity and Neuroprotection

The biological logic established in invertebrate models finds important conceptual extension in mammals, particularly regarding the nervous system. The hormesis principle of neuroplasticity and neuroprotection, as elaborated by [97], argues that mild stressors — including not only heat but also exercise, fasting, and cognitive challenge — activate adaptive neural responses that enhance both structural plasticity and resistance to neurodegenerative insults. A key insight of this framework is that neuroprotection is more robustly achieved by inducing endogenous adaptive programs than by direct pharmacological intervention against specific pathological targets [97, 64]. This reframes therapeutic strategy: rather than targeting individual disease mechanisms downstream, hormetic interventions engage broad-spectrum stress-response networks — an approach supported by evidence that heat shock proteins and autophagy pathways together coordinate neuroprotection across multiple disease contexts [98, 18]. The convergence with the C. elegans molecular findings is striking — HSF-1, autophagy, and proteostasis networks are deeply conserved across metazoan evolution [11, 14], and the principle that mild activation of these systems confers benefit applies from worm intestine to mammalian neuron [86, 18]. Recent work has further demonstrated that heat acclimatisation upregulates HSP70 in a brain-region-specific manner, with expression patterns correlating directly with cognitive protection, and that HSP70’s neuroprotective efficacy derives from its simultaneous coordination of autophagy flux, apoptotic signalling, and neuroinflammatory tone rather than from any single downstream pathway [65]. This network-level view of HSP70’s neuroprotective function reinforces the hormesis framework’s emphasis on broad-spectrum adaptive responses over narrow pathway targeting.

Heat Acclimation, Cross-Tolerance, and Translational Applications

The translational extension of hormesis principles to human health practice centres substantially on sauna use as a readily accessible, dose-controllable thermal stressor. Repeated sauna exposure has been proposed to optimise stress responses through heat shock protein induction and hormetic adaptation, while also replicating many of the physiological demands of aerobic exercise [41]. The cross-tolerance concept — whereby adaptation to one stressor enhances resilience to mechanistically distinct challenges — is particularly relevant here, with sauna-induced heat acclimation linked to benefits extending across cardiovascular, metabolic, and potentially neurological domains [41, 1]. This cross-stressor resilience has a well-characterised cellular basis: heat acclimation upregulates basal intracellular HSP72 levels while blunting the acute post-stress response, and drives broad genomic reprogramming involving upregulation of approximately 130 genes, consistent with a constitutively primed cytoprotective state [27]. Importantly, performance and cardiovascular gains from heat acclimation have also been documented in cool and temperate environments, suggesting that adaptive benefits are not thermally restricted but transfer across distinct physiological challenges [27]. The epigenetic evidence reviewed above provides a further mechanistic substrate for cross-tolerance: chromatin remodelling that constitutively upregulates HSP70 and HSP90 transcriptional networks would be expected to lower the activation threshold for these protective pathways regardless of the nature of the subsequent challenge [95]. As detailed in Section 3, the cardiometabolic evidence supporting sauna as a hormetic cardiovascular stimulus is among the most quantitatively compelling in the human hormesis literature, with dose-dependent reductions in cardiovascular mortality and acute improvements in endothelial function — including enhanced arterial nitric oxide synthase expression and flow-mediated dilation — documented in epidemiological and experimental studies alike [48, 41, 44, 49]. The dose-dependence of these mortality reductions is itself consistent with hormetic dose-response logic, where the relationship between stressor intensity and benefit follows an inverted-U rather than a linear or threshold pattern [48, 17].

Synthesis and Remaining Considerations

Across this literature, a coherent biological narrative emerges: mild heat stress activates conserved transcription factors (HSF-1), induces cellular quality-control programs (autophagy), and in early developmental windows can restructure cellular membranes in ways that persist as durable resilience memories [21, 22]. In humans, these molecular mechanisms are complemented by an epigenetic acclimation memory — encoded through histone acetylation and chromatin remodelling — that sustains constitutive HSP expression, enables remarkably rapid re-acclimation after deacclimation periods, and confers cross-tolerance to non-thermal stressors including oxidative stress and metabolic toxins [95, 29, 17]. Mechanistically, this cross-tolerance is mediated by the same HSP chaperone networks — particularly HSP70 and HSP90 — whose constitutive upregulation reduces the accumulation of oxidatively damaged proteins and enhances proteasomal activity across stressor modalities [17]. These molecular mechanisms find organisational coherence in the hormesis framework as applied to both neural adaptation and cardiometabolic health [97, 41, 48].

The hormetic logic of heat exposure is not unique to thermal stress: caloric restriction and its pharmacological mimetics — including rapamycin, spermidine, and resveratrol — engage overlapping downstream effectors, most notably autophagy induction through the AMPK–mTOR axis and sirtuin-dependent transcriptional programmes [20, 99, 33]. The mTOR pathway in particular represents a nodal convergence point, with rapamycin-mediated mTOR inhibition producing longevity benefits in multiple model organisms through mechanisms that substantially overlap with hormetic heat adaptation [91, 34]. This mechanistic convergence suggests that heat exposure belongs to a broader class of hormetic interventions whose individual contributions may be additive when targeting different upstream nodes of the same protective networks, a possibility explored further in the Discussion.

The translation from C. elegans to human practice is not without inferential distance — the specific molecular pathways identified in worms require systematic validation in mammalian systems, and the epidemiological sauna literature, while compelling in magnitude, cannot fully disentangle thermal hormesis from confounding lifestyle variables. However, the progressive blunting of HSP induction with successful acclimation — demonstrated directly in human leukocytes [30] — introduces a practical complication: it implies that the very success of hormetic adaptation may necessitate periodised protocols, with planned deacclimation intervals or progressive dose escalation, to sustain the full protective response over time [27, 28]. Nonetheless, the convergence across levels of analysis — from tetraspanin membrane webs to epigenetic chromatin marks to cardiovascular mortality statistics — lends the hormesis-heat-longevity axis unusual explanatory coherence and positions it as a productive frontier for both basic mechanistic research and evidence-based health intervention.

8. C. elegans as a Model System for Heat Stress, Aging, and Longevity Pathways

Caenorhabditis elegans emerged as a pivotal model organism for dissecting the molecular architecture of aging and stress responses precisely because its short lifespan, transparent body, genetic tractability, and conservation of core eukaryotic signaling pathways allow investigators to move rapidly from genetic perturbation to organismal phenotype. Decades of work using this nematode have revealed that heat stress, proteostasis maintenance, and lifespan regulation are not independent phenomena but are deeply interwoven through shared transcription factors, signaling cascades, and cellular quality-control machinery. What began as observations about individual stress-response genes has evolved into a systems-level understanding of how the organism integrates thermal cues, metabolic state, and developmental history to calibrate longevity.

HSF-1 and DAF-16/FOXO Cooperation in Lifespan Regulation

The conceptual foundation for understanding longevity-associated stress signaling in C. elegans was substantially advanced in the early 2000s, when genetic analyses established that the heat shock transcription factor HSF-1 is not merely a dedicated emergency responder to proteotoxic insult but a core regulator of lifespan itself. Seminal work by [72] demonstrated that HSF-1 overexpression extends C. elegans lifespan by approximately 40% and, critically, that HSF-1 is required for the lifespan extension conferred by reduced insulin/IGF-1 signaling through daf-2 mutations — placing HSF-1 in the same epistatic hierarchy as the FOXO transcription factor DAF-16. This finding established that the heat shock response and the insulin/IGF-1 longevity pathway are not parallel systems but genuinely cooperative: both transcription factors must be active for full lifespan extension, and each is partially dispensable only in the presence of the other. The broader regulatory logic of HSF-1 as an integrator of stress, development, and lifespan — extending well beyond emergency proteotoxic responses — has since been consolidated across multiple metazoan contexts [11, 12].

The functional significance of this cooperation became clearer as subsequent mechanistic work revealed the fragility of the proteostasis network with age. [24] demonstrated that proteostasis collapse in C. elegans is not a late-life deterioration but an early adulthood event, occurring between days 2 and 7, long before gross physiological decline becomes apparent. Using temperature-sensitive missense mutant proteins as folding sensors distributed across multiple tissues, they showed that misfolding failure is systemic rather than tissue-specific — pointing to a coordinated, organism-wide loss of chaperone buffering capacity. This systemic framing was reinforced conceptually by [16], who articulated that proteostasis depends on precise calibration of chaperone networks to misfolded protein flux rather than on surplus buffering capacity, explaining why even modest perturbations — whether genetic, environmental, or age-related — can destabilize the system [14]. Complementing this picture, [9] synthesized evidence that HSF-1 activity declines sharply in early adulthood, creating a mechanistic link between the aging-associated drop in transcriptional stress responsiveness and the systemic proteostasis collapse documented empirically — a decline that has been further characterized in terms of altered HSF-1 post-translational regulation and chromatin accessibility [12, 18]. Notably, neurons were identified as exhibiting a particularly compromised heat shock response, with selective or incomplete HSF-1 activation relative to other cell types [9] — a cellular heterogeneity consistent with the broader evidence for cell non-autonomous, neurally orchestrated control of organismal proteostasis [23], and one that would later acquire deeper functional significance.

Neuronal Control of Organismal Proteostasis via Thermosensory Neurons

The discovery that neurons play a privileged role in regulating organismal proteostasis — rather than simply experiencing it passively — represents one of the more conceptually significant shifts in the field. Reviews synthesizing temperature-dependent regulation of proteostasis and longevity have highlighted that thermosensory AFD neurons in C. elegans non-autonomously regulate the heat shock response, allowing the organism to distinguish between acute thermal stress and chronic protein misfolding through distinct neuronal and endocrine signaling networks [23]. This non-cell-autonomous architecture — in which peripheral tissues receive proteostatic instructions relayed from the nervous system — means that an organism’s proteostatic state is partly a function of sensory experience and neural computation, not simply of local protein quality [16, 9]. The implication is that temperature influences aging through genetically regulated information-processing circuits rather than through passive thermodynamic effects on molecular stability alone [23]. This is further supported by evidence that olfactory and other sensory neurons can similarly extend lifespan through TGF-β signaling and unfolded protein response activation, suggesting a broader principle of sensory-neuronal governance of systemic proteostasis [88]. This neuronal regulatory axis provides a mechanistic bridge between the well-documented temperature dependence of C. elegans lifespan [14] and the molecular pathways that execute lifespan determination.

Autophagy as a Mediator of Heat-Shock-Induced Longevity

A parallel line of investigation has focused on how HSF-1 translates thermal stress signals into beneficial adaptive outcomes beyond immediate chaperone induction. [21] provided direct evidence that mild hormetic heat shock — one hour at 36°C — induces autophagy across multiple tissues in C. elegans, including hypodermal seam cells, body-wall muscle, neurons, and intestinal cells. Crucially, HSF-1 was identified as a key regulator of this autophagic induction, with HSF-1 overexpression sufficient to increase autophagosomal structures and autophagy gene expression even in the absence of external stress — consistent with broader evidence that HSF-1 activity is a central determinant of lifespan [72, 11]. This finding positioned autophagy not merely as a parallel stress response pathway but as a downstream effector of HSF-1 activity, mechanistically linking the transcription factor’s longevity-promoting functions to organellar protein clearance [87, 39]. The tissue-breadth of autophagy induction also resonated with earlier evidence for systemic proteostasis regulation [16, 9], suggesting that hormetic heat stress coordinates a whole-organism autophagic response rather than a cell-autonomous one. Further reinforcing this picture, the autophagy receptor p62/SQST-1 has itself been shown to promote proteostasis and longevity in C. elegans by sustaining autophagic flux [100], underscoring the importance of robust cargo-selective autophagy as a downstream arm of the HSF-1-mediated stress response.

Mitochondrial ETC Mutations and Hormetic ROS Signaling

The theme of hormesis extends beyond the heat shock and autophagy axes to encompass mitochondrial signaling. Recent work has extended the hormesis framework to the mitochondrial electron transport chain [89], demonstrating that C. elegans mutations in Complex I and III ETC genes — including nuo-6, gas-1, and isp-1 — extend lifespan through hormetic reactive oxygen species (ROS) signaling mechanisms, whereby transient ROS elevation activates protective stress-response pathways [89]. These mutant strains also recapitulate human mitochondrial disease phenotypes including lactic acidosis and muscle weakness, positioning C. elegans as a translationally relevant system for understanding how mitochondrial dysfunction intersects with aging [89]. Critically, C. elegans encodes orthologs of 72 of the 91 human ETC-encoding genes, underpinning its broad conservation with the human mitochondrial system [89]. The hormetic ROS model — sometimes termed mitohormesis [90] — joins a broader conceptual framework in which moderate cellular stress — whether thermal, proteotoxic, or metabolic — activates conserved longevity pathways, while excessive or chronic stress overwhelms them [18].

Early-Life Stress Memory and Tetraspanin-Based Resilience

Among the most conceptually novel contributions to emerge from the C. elegans aging field is the demonstration that early-life thermal stress can encode durable cellular memory that persists long after the stressor has been removed. [22] showed that early-life thermal stress induces persistent upregulation of the tetraspanin TSP-1 through the histone acetyltransferase CBP-1, operating independently of the canonical HSF-1 heat shock response — a pathway otherwise well-established as the primary transcriptional mediator of acute proteotoxic stress [12, 11]. TSP-1 assembles into stable, high-molecular-weight multimeric web structures at the apical intestinal membrane that endure well beyond the stress episode, constituting a structural form of cellular memory rather than a transcriptional one. This epigenetic route to stress memory is consistent with broader evidence that chromatin-modifying enzymes can remodel gene expression landscapes in response to environmental challenge [94]. This work represents a significant departure from models in which stress responses are transient and reversible [9], suggesting instead that early environmental experience can remodel cellular architecture in ways that confer lasting organismal resilience.

Temperature-Dependent Lifespan Regulation

Underpinning all of these mechanisms is the empirically established sensitivity of C. elegans lifespan to ambient temperature — a relationship that is not merely a passive reflection of biochemical reaction rates but is actively modulated through the neuronal and endocrine circuits described above [23]. The declining inducibility of the heat shock response with age, despite elevated basal HSP expression, has been attributed to defects in HSF-1 signal transduction and age-related declines in SIRT1 expression [18, 12]. Mechanistically, stress-inducible acetylation of HSF-1 lysine residues — normally counteracted by SIRT1 deacetylase activity — impairs HSF-1 DNA binding, trimerization, and nuclear localization; as SIRT1 levels fall with age, this brake on HSF-1 activity becomes constitutive [12]. Compounding this, proteostasis collapse in C. elegans has been shown to occur as an early and discrete event in adulthood, with both the heat shock response and the unfolded protein response becoming significantly dampened as early as day four of adult life — well before broad physiological decline is apparent [24]. This reveals a paradox in which aged animals carry more misfolded protein burden yet are less capable of mounting the transcriptional response needed to address it [9]. Together, the body of work reviewed here — spanning foundational discoveries in HSF-1/DAF-16 cooperation, systemic proteostasis collapse, neuronal non-autonomy, autophagic hormesis, mitochondrial ROS signaling, and epigenetically encoded structural memory — illustrates the remarkable explanatory power that C. elegans continues to offer as a system for interrogating the conserved biology of heat stress and aging.

9. Discussion

The body of evidence synthesized in this review reveals a coherent, multi-level account of how repeated heat exposure translates into measurable health benefits — one that now spans molecular mechanism, invertebrate genetics, human exercise physiology, and population epidemiology in ways that were only fragmentarily connected a few years ago. What has changed most sharply in recent work is not the discovery of entirely new components but rather the integration of previously siloed findings into a unified mechanistic picture, and it is worth examining what that integration implies for both scientific understanding and clinical practice.

The most consequential conceptual advance is the consolidation of HSF-1 as the linchpin connecting acute thermal stress to long-term organismal outcomes. Research in C. elegans has been particularly generative here, demonstrating that HSF-1 does not act in isolation but sits at the intersection of the insulin/IGF-1 signaling axis, the mitochondrial unfolded protein response, and chromatin remodeling machinery. These findings reframe HSF-1 from a simple emergency transcription factor into a chronic regulator of proteostatic capacity, one whose baseline activity — not merely its stress-induced peaks — appears to set a ceiling on how well an organism can buffer the protein damage that accumulates with age. This mechanistic reframing matters because it implies that interventions capable of sustaining or periodically resetting HSF-1 activity across the lifespan may have fundamentally different effects than single acute exposures, a distinction that has not yet been adequately captured in human trial designs.

The proteostasis literature reinforces this point from another angle. The progressive collapse of protein quality control during aging — involving coordinated declines in chaperone induction capacity, ubiquitin-proteasome throughput, and autophagic flux — is now understood not as the failure of any single component but as an emergent systems-level deterioration. Critically, heat shock proteins such as HSP70 and HSP90 are not merely downstream effectors in this system; they are also structural organizers of the ubiquitin-proteasome and autophagy pathways themselves. The implication is that thermally induced upregulation of these chaperones may provide a form of network-level rescue that is broader than any single pathway intervention, which may partly explain the striking breadth of benefit observed in epidemiological datasets.

A second major mechanistic axis — and one that has been insufficiently integrated in prior accounts — concerns the anti-inflammatory consequences of HSF-1 activation. The recognition that HSF-1 directly antagonises NF-κB transcriptional activity, and that its downstream effectors including HSP70 further suppress inflammasome activation and pro-inflammatory cytokine signalling, establishes inflammation as a parallel and complementary pathway through which repeated heat exposure confers protection. This is consequential because the diseases most robustly associated with sauna use in epidemiological data — cardiovascular disease, stroke, dementia, and all-cause mortality — are precisely those in which chronic low-grade inflammation, or inflammaging, has been identified as a central pathogenic driver [54, 55, 80]. The convergence is not coincidental: inflammaging and proteostasis failure share upstream regulators (SIRT1 decline, NF-κB disinhibition) and downstream consequences (impaired autophagy, oxidative damage accumulation), meaning that periodic HSF-1 reactivation through heat exposure may simultaneously rescue both arms of this age-related deterioration. The HSF-1/NF-κB axis thus provides the molecular mechanism that was previously missing from accounts claiming anti-inflammatory benefits for sauna use — transforming what had been an empirical observation into a mechanistically grounded prediction.

Bridging the Translational Gap: What Human Evidence Confirms

The exercise physiology and heat acclimation literature provides a critical empirical bridge between the invertebrate genetic findings and population-level epidemiological observations. Several key findings substantiate the translational relevance of the molecular mechanisms identified in model organisms. First, the demonstration that core temperature elevation — not mechanical exercise — is the primary driver of HSP70 upregulation in human leukocytes [30] confirms that the chaperone-mediated cytoprotective pathway can be engaged by passive thermal stress alone, validating the mechanistic basis for sauna-based interventions. Second, the quantification of acclimation kinetics — with plasma volume expansion exceeding 5% and the majority of cardiovascular adaptations achieved within four to seven days [27, 28] and re-acclimation proceeding eight to twelve times faster than initial acclimation [29] — provides the temporal parameters needed to design evidence-based protocols. Third, the epigenetic stabilisation of the acclimated phenotype through histone acetylation and chromatin remodelling [95] offers a molecular explanation for why habitual sauna users maintain elevated baseline cytoprotection — expressed in part through constitutively higher intracellular HSP levels and enhanced proteasomal activity [17] — and experience rapid restoration of benefits after periods of reduced use.

However, these human findings also expose a productive tension. The progressive blunting of acute HSP induction with successful acclimation [30, 28] means that the molecular signal hypothesised to drive long-term benefit diminishes precisely as adaptation succeeds. This paradox has not been satisfactorily resolved and carries direct implications for protocol design: whether sustained benefit requires progressive dose escalation, periodic deacclimation intervals, or whether the elevated constitutive baseline alone is sufficient for ongoing protection remains an open empirical question. The decay kinetics of approximately 2.3–2.6% per day for cardiovascular adaptations [29] suggest that a periodised approach — with two-to-three-week withdrawal windows followed by brief re-acclimation blocks — warrants systematic investigation, particularly given that sudomotor adaptations such as sweating threshold and sensitivity require more than ten days to fully consolidate [28] and may decay on different timescales than cardiovascular indices.

Heat Exposure Within the Broader Geroscience Intervention Landscape

Perhaps the most significant contextual shift required for interpreting the evidence reviewed here is the recognition that heat exposure does not operate in a mechanistic vacuum but engages the same conserved molecular pathways now being targeted by the most promising pharmacological geroscience interventions. The geroscience hypothesis — that aging itself, understood as a constellation of interconnected molecular deteriorations organised around the hallmarks framework, is the primary risk factor underlying multiple chronic diseases — predicts that interventions targeting these hallmarks should compress morbidity across disease categories simultaneously rather than addressing each sequentially [19, 54]. The epidemiological profile of habitual sauna use, with its simultaneous reductions in cardiovascular mortality, dementia incidence, stroke, and all-cause mortality, is precisely what this hypothesis would predict for an intervention engaging multiple aging hallmarks concurrently.

The mechanistic overlaps are specific and substantive. The most extensively studied pharmacological geroprotector, rapamycin, extends lifespan more reproducibly across model organisms than any other single compound, principally through inhibition of mTORC1 and consequent restoration of autophagic flux [19, 20]. Heat exposure engages autophagy through a parallel but upstream route: HSF-1 activation directly induces autophagy gene expression and autophagosome formation across multiple tissues [21], while the AMPK activation that accompanies thermal metabolic stress further suppresses mTORC1 [99]. The convergence on autophagy as a shared downstream effector is noteworthy because it suggests that heat exposure and rapamycin may achieve overlapping proteostatic benefits through mechanistically distinct upstream signals — a configuration that, in pharmacological terms, would be described as convergent rather than redundant and that could in principle support additive or even synergistic effects in combination.

The NAD⁺ precursor literature intersects with heat exposure biology at an equally specific molecular node. NAD⁺ levels decline progressively with age across species — a decline documented in human skeletal muscle, liver, and blood [35, 32] — and this decline compromises the activity of sirtuins — the NAD⁺-dependent deacetylases that, among other functions, maintain HSF-1 in a transcriptionally competent state by deacetylating its DNA-binding domain [11, 82]. NMN and NR supplementation aims to restore sirtuin activity through substrate repletion, and emerging human data suggest measurable benefits in older adults with baseline NAD⁺ depletion [20, 101]. Heat exposure may complement this strategy from the demand side: by periodically activating HSF-1 and thereby creating a functional requirement for SIRT1-mediated deacetylation, thermal stress may enhance the biological utility of any NAD⁺ that is available, whether endogenous or exogenously supplemented. The prediction that follows — that NAD⁺ precursor supplementation should amplify the HSP-inductive and anti-inflammatory effects of heat exposure, particularly in older adults whose NAD⁺ depletion limits SIRT1-dependent HSF-1 maintenance — is mechanistically grounded and empirically testable, though no trial has yet examined this combination directly.

The senotherapeutic field provides a third axis of convergence. Cellular senescence and the SASP have been identified as central mediators of inflammaging, with senescent cells accumulating across cardiovascular, endocrine, and neural tissues and secreting pro-inflammatory cytokines that drive the very diseases against which sauna use appears protective [52, 78, 84]. Senolytic agents such as dasatinib plus quercetin eliminate senescent cells directly, while senomorphic agents including rapamycin suppress SASP output without inducing cell death [85]. Heat exposure operates through a complementary mechanism: rather than eliminating senescent cells or pharmacologically suppressing SASP transcription, periodic HSF-1 activation antagonises NF-κB — the master transcriptional driver of SASP — while HSP70 induction further suppresses NLRP3 inflammasome assembly and stabilises IκBα, attenuating downstream inflammatory signalling [58, 65]. This mechanistic distinction is important because it suggests that heat exposure could attenuate the inflammatory consequences of senescent cell accumulation even in the absence of senolytic clearance, and conversely, that senolytic therapy could reduce the senescent cell burden that heat exposure alone cannot address. The combination of senolytic clearance with heat-induced anti-inflammatory signalling would target inflammaging at two distinct levels — source reduction and signal suppression — potentially achieving more durable inflammatory attenuation than either approach in isolation.

A further point of mechanistic intersection concerns the antioxidant transcription factor NRF2, which coordinates redox homeostasis with protein quality control through a regulon of over 250 target genes [81]. NRF2 activation follows a hormetic dose-response curve strikingly parallel to that documented for heat exposure itself: moderate activation extends healthspan, while both insufficient and constitutive activation are deleterious [81]. Heat stress engages NRF2-dependent pathways through the oxidative component of thermal challenge, and the antagonistic crosstalk between NF-κB and NRF2 [80] suggests that HSF-1-mediated suppression of NF-κB during heat exposure may indirectly relieve NRF2 from NF-κB-dependent repression, creating a permissive environment for antioxidant gene expression. This multi-transcription-factor model — in which a single thermal stimulus simultaneously activates HSF-1, relieves NF-κB-mediated suppression of NRF2, and engages autophagy through AMPK — begins to explain why heat exposure produces benefits across such a mechanistically diverse range of conditions, a breadth of effect that would be difficult to achieve through any single pharmacological agent targeting one pathway in isolation.

Methodological Implications: Toward Geroscience-Informed Trial Design

The maturation of the geroscience field offers important methodological lessons for heat exposure research. Rapamycin and metformin trials have established precedents for using biological age clocks, composite healthspan endpoints, and multi-organ biomarker panels to assess interventions that target aging mechanisms rather than individual diseases [19, 20]. A dedicated framework for selecting blood-based biomarkers in geroscience-guided clinical trials has since been articulated [102], and epigenetic pace-of-aging measures such as DunedinPACE now offer sensitive, validated tools for detecting biological age change within feasible study windows [103, 104]. The heat exposure field has yet to adopt these methodological frameworks: existing trials predominantly measure single-system surrogate outcomes (blood pressure, flow-mediated dilatation, glycaemic markers) over weeks to months [46, 43], designs that are unlikely to capture the multi-system, hallmark-level benefits suggested by the molecular evidence. The absence of validated geroscience biomarkers — measures of senescent cell burden [83], NAD⁺ metabolism, and biological age that are sensitive enough to detect healthspan improvements within feasible trial timeframes — is a limitation shared across the geroscience intervention landscape [84, 85, 105], but one that heat exposure research must address if it is to move beyond cardiovascular surrogate endpoints.

The geroscience literature also sharpens the question of whether heat exposure offers genuinely additive benefit when combined with pharmacological interventions, or whether pathway redundancy limits combinatorial gains. Recent preclinical evidence indicates that some geroprotector combinations — such as trametinib and rapamycin — can produce additive lifespan and healthspan extension, suggesting that pathway complementarity, rather than redundancy, may sometimes prevail [106]. Nevertheless, the context-dependence of autophagy — cytoprotective during ischaemia but potentially cytotoxic during reperfusion, as demonstrated in cardiac models [99] — cautions against assuming that more autophagy induction is uniformly beneficial. Similarly, the non-monotonic dose-response relationships documented for NRF2 [81] and hormetic heat stress alike [21, 17] suggest that combining multiple autophagy- and proteostasis-activating interventions could in principle push adaptive responses past their optimal range. Rigorous combinatorial trials — comparing heat exposure alone, pharmacological geroprotectors alone, and their combination, with shared biological aging endpoints — represent the experimental design most capable of resolving this question but have not yet been undertaken.

Limitations and Outstanding Uncertainties

Several important limitations constrain the conclusions that can be drawn from this synthesis. The epidemiological foundation, while compelling in its dose-response architecture and mortality effect sizes, remains substantially restricted to Finnish male cohorts of Northern European heritage [3, 5], limiting generalisability to women, non-European populations, and individuals with comorbidities that may alter thermoregulatory capacity or inflammatory profiles. Notably, one of the few studies to include women found comparable stroke-risk reductions [6], but systematic female-specific or ethnically diverse cohort data remain sparse. The molecular mechanisms identified in C. elegans — including HSF-1/DAF-16 cooperation [72], tetraspanin-based structural memory, and neuronal non-autonomous regulation of proteostasis [23] — remain incompletely validated in mammalian systems [9, 12], and the inferential distance between nematode genetics and human physiology, while bridgeable in principle, has not been systematically calibrated. The metabolic ceiling observed in at least one well-designed intervention trial — where hot-water immersion produced no glycaemic improvement despite cardiovascular benefits [43] — suggests that heat exposure does not uniformly engage all aging-relevant metabolic pathways, a limitation that must temper claims of comprehensive geroprotective action. The progressive blunting of acute HSP induction with repeated exposure [28, 30], while interpretable as successful adaptation, nonetheless raises unresolved questions about whether long-term habitual sauna users continue to derive the molecular benefits hypothesised to underlie their epidemiological protection. Finally, the broader geroscience comparison highlights a significant asymmetry: whereas rapamycin, senolytics, and NAD⁺ precursors have entered early-phase human trials with standardised dosing and biomarker panels [32, 107], heat exposure research lacks equivalent protocol standardisation, making cross-study comparison and meta-analytic synthesis substantially more difficult.

Future Directions

Closing these gaps will require a coordinated programme of research operating at multiple levels simultaneously. At the molecular level, mammalian validation of the HSF-1-driven autophagy, anti-inflammatory, and proteostatic mechanisms demonstrated in C. elegans [21, 100] remains the highest priority, with tissue-specific conditional knockout models offering the most direct experimental path. The broader systems-level architecture of HSF-1 as a transcriptional regulator of proteostasis [9, 12] and its interaction with temperature-dependent longevity networks [23] underscores why these mammalian translational experiments are so consequential. At the clinical level, adequately powered randomised controlled trials with diverse populations, standardised thermal protocols, and composite biological aging endpoints — including epigenetic clocks [103, 104], circulating SASP biomarkers such as IL-6 and GDF-15 [36, 102], NAD⁺ metabolomics, and senescence indicators [108] — are needed to determine whether the benefits observed in observational cohorts survive rigorous causal testing. Head-to-head and combinatorial trials comparing heat exposure with pharmacological geroprotectors — rapamycin [92, 107], metformin, NAD⁺ precursors, and senolytic regimens [32, 37] — using harmonised aging biomarker panels [102] would directly test whether mechanistic convergence translates into clinical redundancy or additive benefit. The periodisation question — whether cyclical protocols with planned deacclimation intervals outperform continuous exposure — is amenable to crossover trial designs informed by the acclimation decay kinetics already quantified in the exercise physiology literature [29]. Finally, population-specific safety and efficacy data for older adults, women, and individuals with cardiovascular or metabolic comorbidities must be generated before heat exposure can be responsibly incorporated into clinical guidelines.

The evidence reviewed here establishes that repeated heat exposure is not merely a traditional wellness practice with epidemiological associations but a mechanistically grounded intervention engaging the same conserved longevity pathways — proteostasis maintenance [9, 86], autophagy induction [21], inflammaging attenuation [54, 36], and sirtuin-dependent transcriptional regulation [35] — that define the frontier of geroscience pharmacology [32, 20]. Its distinctive advantages — accessibility, low cost, minimal pharmacological risk, and the capacity to engage multiple hallmarks of aging [19] through a single physiological stimulus — position it as a uniquely valuable complement to the pharmacological geroprotective strategies now entering clinical development [37, 107]. Whether this complementarity can be empirically confirmed, and whether the mechanistic convergence documented here translates into additive clinical benefit when heat exposure is combined with targeted geroprotectors, represents among the most consequential and actionable questions at the intersection of lifestyle medicine and geroscience.

---

References

[1] Laukkanen, J., Laukkanen, T., Kunutsor, S. (2018). Cardiovascular and Other Health Benefits of Sauna Bathing: A Review of the Evidence. Mayo Clinic Proceedings. [2] Heinonen, I., Laukkanen, J. (2018). Effects of heat and cold on health, with special reference to Finnish sauna bathing. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. [3] Laukkanen, T., Kunutsor, S., Khan, H., et al. (2018). Sauna bathing is associated with reduced cardiovascular mortality and improves risk prediction in men and women: a prospective cohort study. BMC Medicine. [4] Laukkanen, T., Kunutsor, S., Kauhanen, J., et al. (2016). Sauna bathing is inversely associated with dementia and Alzheimer’s disease in middle-aged Finnish men. Age and Ageing. [5] Kunutsor, S., Jae, S., Kurl, S., et al. (2022). Inflammation, sauna bathing, and all-cause mortality in middle-aged and older Finnish men: a cohort study. European Journal of Epidemiology. [6] Kunutsor, S., Khan, H., Zaccardi, F., et al. (2018). Sauna bathing reduces the risk of stroke in Finnish men and women: A prospective cohort study. Neurology. [7] Laukkanen, J., Jae, S., Kauhanen, J., et al. (2023). The Interplay between Systolic Blood Pressure, Sauna Bathing, and Cardiovascular Mortality in Middle-Aged and Older Finnish Men: A Cohort Study. The journal of nutrition health & aging. [8] Kunutsor, S., Jae, S., Kurl, S., et al. (2024). Sauna bathing and mortality risk: unraveling the interaction with systolic blood pressure in a cohort of Finnish men. Scandinavian Cardiovascular Journal. [9] Morimoto, R. (2011). The Heat Shock Response: Systems Biology of Proteotoxic Stress in Aging and Disease. Cold Spring Harbor Symposia on Quantitative Biology. [10] Singh, M., Shin, Y., Ju, S., et al. (2024). Heat Shock Response and Heat Shock Proteins: Current Understanding and Future Opportunities in Human Diseases. International Journal of Molecular Sciences. [11] Åkerfelt, M., Morimoto, R., Sistonen, L. (2010). Heat shock factors: integrators of cell stress, development and lifespan. Nature Reviews Molecular Cell Biology. [12] Anckar, J., Sistonen, L. (2011). Regulation of HSF1 Function in the Heat Stress Response: Implications in Aging and Disease. Annual Review of Biochemistry. [13] Kovács, D., Sigmond, T., Hotzi, B., et al. (2019). HSF1Base: A Comprehensive Database of HSF1 (Heat Shock Factor 1) Target Genes. International Journal of Molecular Sciences. [14] Labbadia, J., Morimoto, R. (2015). The Biology of Proteostasis in Aging and Disease. Annual Review of Biochemistry. [15] Klaips, C., Jayaraj, G., Hartl, F. (2018). Pathways of cellular proteostasis in aging and disease. The Journal of Cell Biology. [16] Gidalevitz, T., Prahlad, V., Morimoto, R. (2011). The Stress of Protein Misfolding: From Single Cells to Multicellular Organisms. Cold Spring Harbor Perspectives in Biology. [17] Rattan, S. (2004). Hormetic Mechanisms of Anti-Aging and Rejuvenating Effects of Repeated Mild Heat Stress on Human Fibroblasts in Vitro. Rejuvenation Research. [18] Kourtis, N., Tavernarakis, N. (2011). Cellular stress response pathways and ageing: intricate molecular relationships. The EMBO Journal. [19] Guo, J., Huang, X., Dou, L., et al. (2022). Aging and aging-related diseases: from molecular mechanisms to interventions and treatments. Signal Transduction and Targeted Therapy. [20] Mishra, S., Balendra, V., Esposto, J., et al. (2022). Therapeutic Antiaging Strategies. Biomedicines. [21] Kumsta, C., Chang, J., Schmalz, J., et al. (2017). Hormetic heat stress and HSF-1 induce autophagy to improve survival and proteostasis in C. elegans. Nature Communications. [22] Jiang, W., De Belly, H., Wang, B., et al. (2024). Early-life stress triggers long-lasting organismal resilience and longevity via tetraspanin. Science Advances. [23] Vakkayil, K., Hoppe, T. (2022). Temperature-Dependent Regulation of Proteostasis and Longevity. Frontiers in Aging. [24] Ben‐Zvi, A., Miller, E., Morimoto, R. (2009). Collapse of proteostasis represents an early molecular event in Caenorhabditis elegans aging. Proceedings of the National Academy of Sciences. [25] Singh, R. (2007). Genetics of human longevity with emphasis on the relevance of HSP70 as candidate genes. Frontiers in bioscience. [26] Rodrigues, P., Orssatto, L., Gagnon, D., et al. (2024). Passive heat therapy: a promising preventive measure for people at risk of adverse health outcomes during heat extremes. Journal of Applied Physiology. [27] Périard, J., Racinais, S., Sawka, M. (2014). Adaptations and mechanisms of human heat acclimation: Applications for competitive athletes and sports. Scandinavian Journal of Medicine and Science in Sports. [28] Corbett, J., Young, J., Tipton, M., et al. (2023). Molecular biomarkers for assessing the heat‑adapted phenotype: a narrative scoping review. The Journal of Physiological Sciences. [29] Daanen, H., Racinais, S., Périard, J. (2017). Heat Acclimation Decay and Re-Induction: A Systematic Review and Meta-Analysis. Sports Medicine. [30] Magalhães, F., Amorim, F., Passos, R., et al. (2010). Heat and exercise acclimation increases intracellular levels of Hsp72 and inhibits exercise-induced increase in intracellular and plasma Hsp72 in humans. Cell Stress and Chaperones. [31] Brunt, V., Minson, C. (2021). Heat therapy: mechanistic underpinnings and applications to cardiovascular health. Journal of Applied Physiology. [32] Campisi, J., Kapahi, P., Lithgow, G., et al. (2019). From discoveries in ageing research to therapeutics for healthy ageing. Nature. [33] Papadopoli, D., Boulay, K., Kazak, L., et al. (2019). mTOR as a central regulator of lifespan and aging. F1000Research. [34] Mannick, J., Lamming, D. (2023). Targeting the biology of aging with mTOR inhibitors. Nature Aging. [35] Grabowska, W., Sikora, E., Bielak-Żmijewska, A. (2017). Sirtuins, a promising target in slowing down the ageing process. Biogerontology. [36] Zhu, X., Chen, Z., Shen, W., et al. (2021). Inflammation, epigenetics, and metabolism converge to cell senescence and ageing: the regulation and intervention. Signal Transduction and Targeted Therapy. [37] Li, Z., Zhang, Z., Ren, Y., et al. (2021). Aging and age‐related diseases: from mechanisms to therapeutic strategies. Biogerontology. [38] Todorova, M., Savova, M., Mihaylova, L., et al. (2024). Nurturing longevity through natural compounds: Where do we stand, and where do we go?. Food Frontiers. [39] Hansen, M., Chandra, A., Mitic, L., et al. (2008). A Role for Autophagy in the Extension of Lifespan by Dietary Restriction in C. elegans. PLoS Genetics. [40] Sőti, C., Nagy, E., Giricz, Z., et al. (2005). Heat shock proteins as emerging therapeutic targets. British Journal of Pharmacology. [41] Patrick, R., Johnson, T. (2021). Sauna use as a lifestyle practice to extend healthspan. Experimental Gerontology. [42] Sébastien Racinais, Mathew G Wilson, Julien D. Périard (2016). Passive heat acclimation improves skeletal muscle contractility in humans. American Journal of Physiology-Regulatory, Integrative and Comparative Physiology. [43] Roxburgh, B., Campbell, H., Cotter, J., et al. (2023). Acute and adaptive cardiovascular and metabolic effects of passive heat therapy or high-intensity interval training in patients with severe lower-limb osteoarthritis. Physiological Reports. [44] Ikeda, Y., Biro, S., Kamogawa, Y., et al. (2005). Repeated Sauna Therapy Increases Arterial Endothelial Nitric Oxide Synthase Expression and Nitric Oxide Production in Cardiomyopathic Hamsters. Circulation Journal. [45] Akerman, A., Lucas, S., Katare, R., et al. (2017). Heat and Dehydration Additively Enhance Cardiovascular Outcomes following Orthostatically-Stressful Calisthenics Exercise. Frontiers in Physiology. [46] Faith K. Pizzey, Emily C. Smith, Stefanie L. Ruediger, et al. (2021). The effect of heat therapy on blood pressure and peripheral vascular function: A systematic review and meta‐analysis. Experimental Physiology. [47] Guimarães, G., Cruz, L., Fernandes-Silva, M., et al. (2014). Heated water-based exercise training reduces 24-hour ambulatory blood pressure levels in resistant hypertensive patients: A randomized controlled trial (HEx trial). International Journal of Cardiology. [48] Henderson, K., Killen, L., O’Neal, E., et al. (2021). The Cardiometabolic Health Benefits of Sauna Exposure in Individuals with High-Stress Occupations. A Mechanistic Review. International Journal of Environmental Research and Public Health. [49] Gravel, H., Coombs, G., Behzadi, P., et al. (2019). Acute effect of Finnish sauna bathing on brachial artery flow-mediated dilation and reactive hyperemia in healthy middle-aged and older adults. Physiological Reports. [50] Peng, Y., Zou, Y., Asakawa, T. (2025). The glamor of and insights regarding hydrotherapy, from simple immersion to advanced computer-assisted exercises: A narrative review. BioScience Trends. [51] Jari A. Laukkanen, Setor K. Kunutsor (2024). The multifaceted benefits of passive heat therapies for extending the healthspan: A comprehensive review with a focus on Finnish sauna. Temperature. [52] Birch, J., Gil, J. (2020). Senescence and the SASP: many therapeutic avenues. Genes & Development. [53] van der Rijt, S., Molenaars, M., McIntyre, R., et al. (2020). Integrating the Hallmarks of Aging Throughout the Tree of Life: A Focus on Mitochondrial Dysfunction. Frontiers in Cell and Developmental Biology. [54] Franceschi, C., Garagnani, P., Morsiani, C., et al. (2018). The Continuum of Aging and Age-Related Diseases: Common Mechanisms but Different Rates. Frontiers in Medicine. [55] Rea, I., Gibson, D., McGilligan, V., et al. (2018). Age and Age-Related Diseases: Role of Inflammation Triggers and Cytokines. Frontiers in Immunology. [56] Li, X., Li, C., Zhang, W., et al. (2023). Inflammation and aging: signaling pathways and intervention therapies. Signal Transduction and Targeted Therapy. [57] Bleve, A., Motta, F., Durante, B., et al. (2022). Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases. Clinical Reviews in Allergy & Immunology. [58] Muralidharan, S., Mandrekar, P. (2013). Cellular stress response and innate immune signaling: integrating pathways in host defense and inflammation. Journal of Leukocyte Biology. [59] Maley, M., Hunt, A., Stewart, I., et al. (2019). Passive heating and glycaemic control in nondiabetic and diabetic individuals: A systematic review and meta-analysis. PLoS ONE. [60] Wei, H., Zhang, Y., Jia, Y., et al. (2024). Heat shock protein 90: biological functions, diseases, and therapeutic targets. MedComm. [61] Radons, J. (2016). The human HSP70 family of chaperones: where do we stand?. Cell Stress and Chaperones. [63] Liu, B., Qian, D. (2024). Hsp90α and cell death in cancers: a review. Discover Oncology. [64] Penke, B., Bogár, F., Crul, T., et al. (2018). Heat Shock Proteins and Autophagy Pathways in Neuroprotection: From Molecular Bases to Pharmacological Interventions. International Journal of Molecular Sciences. [65] Su, Y., Zheng, X. (2025). HSP70-Mediated Autophagy-Apoptosis-Inflammation Network and Neuroprotection Induced by Heat Acclimatization. Biology. [66] Singh, M., Shin, Y., Han, S., et al. (2024). Molecular Chaperonin HSP60: Current Understanding and Future Prospects. International Journal of Molecular Sciences. [68] Rukes, V., Rebeaud, M., Perrin, L., et al. (2024). Single-molecule evidence of Entropic Pulling by Hsp70 chaperones. Nature Communications. [69] Dhama, K., Latheef, S., Dadar, M., et al. (2019). Biomarkers in Stress Related Diseases/Disorders: Diagnostic, Prognostic, and Therapeutic Values. Frontiers in Molecular Biosciences. [70] Hooper, P., Balogh, G., Rivas, E., et al. (2014). The importance of the cellular stress response in the pathogenesis and treatment of type 2 diabetes. Cell Stress and Chaperones. [71] János Barna, Péter Csermely, Tibor Vellai (2018). Roles of heat shock factor 1 beyond the heat shock response. Cellular and Molecular Life Sciences. [72] Hsu, A., Murphy, C., Kenyon, C. (2003). Regulation of Aging and Age-Related Disease by DAF-16 and Heat-Shock Factor. Science. [73] Xu, F., Li, R., von Gromoff, E., et al. (2023). Reprogramming of the transcriptome after heat stress mediates heat hormesis in Caenorhabditis elegans. Nature Communications. [74] Bektas, A., Schurman, S., Sen, R., et al. (2017). Human T cell immunosenescence and inflammation in aging. Journal of Leukocyte Biology. [75] Chung, H., Kim, D., Lee, E., et al. (2019). The document appears to be a PDF with binary content and metadata. Based on the metadata stream, it was created using Microsoft® Word for Office 365 on 2019-04-01. However, the main content appears to be binary/compressed data, making it difficult to extract a specific document title, authors, or other bibliographic details from the provided content.. Aging and Disease. [76] Dodig, S., Čepelak, I., Pavić, I. (2019). Hallmarks of senescence and aging. Biochemia Medica. [77] Xia, S., Zhang, X., Zheng, S., et al. (2016). We collect and process your personal information for the following purposes: Authentication, Preferences, Acknowledgement and Statistics. Journal of Immunology Research. [78] Suda, M., Paul, K., Minamino, T., et al. (2023). Senescent Cells: A Therapeutic Target in Cardiovascular Diseases. Cells. [79] Salminen, A., Hyttinen, J., Kauppinen, A., et al. (2012). Context-Dependent Regulation of Autophagy by IKK-NF-κB Signaling: Impact on the Aging Process. International Journal of Cell Biology. [80] Arthur José Pontes Oliveira de Almeida, Mathania Silva de Almeida Rezende, Sabine Helena Dantas, et al. (2020). Unveiling the Role of Inflammation and Oxidative Stress on Age-Related Cardiovascular Diseases. Oxidative Medicine and Cellular Longevity. [81] Buttari, B., Tramutola, A., Rojo, A., et al. (2025). Proteostasis Decline and Redox Imbalance in Age-Related Diseases: The Therapeutic Potential of NRF2. Biomolecules. [82] Odoh, C., Guo, X., Arnone, J., et al. (2022). The role of NAD and NAD precursors on longevity and lifespan modulation in the budding yeast, Saccharomyces cerevisiae. Biogerontology. [83] Robbins, P., Jurk, D., Khosla, S., et al. (2021). Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span. The Annual Review of Pharmacology and Toxicology. [84] Suda, M., Paul, K., Tripathi, U., et al. (2024). Targeting Cell Senescence and Senolytics: Novel Interventions for Age-Related Endocrine Dysfunction. Endocrine Reviews. [85] Calabrò, A., Accardi, G., Aiello, A., et al. (2024). Attenzione: i dati modificati non sono ancora stati salvati. Per confermare inserimenti o cancellazioni di voci è necessario confermare con il tasto SALVA/INSERISCI in fondo alla pagina. International Journal of Molecular Sciences. [86] Margulis, B., Цимоха, А., Зубова, С., et al. (2020). Molecular Chaperones and Proteolytic Machineries Regulate Protein Homeostasis in Aging Cells. Cells. [87] Vı́lchez, D., Sáez, I., Dillin, A. (2014). The role of protein clearance mechanisms in organismal ageing and age-related diseases. Nature Communications. [88] De‐Souza, E., Thompson, M., Taylor, R. (2023). Olfactory chemosensation extends lifespan through TGF-β signaling and UPR activation. Nature Aging. [89] Ősz, F., Nazir, A., Takács‐Vellai, K., et al. (2025). Mutations of the Electron Transport Chain Affect Lifespan and ROS Levels in C. elegans. Antioxidants. [90] Sun, Y., Jin, L., Qin, Y., et al. (2024). Harnessing Mitochondrial Stress for Health and Disease: Opportunities and Challenges. Biology. [91] Blagosklonny, M. (2011). Hormesis does not make sense except in the light of TOR-driven aging. Aging. [92] Lamming, D., Ye, L., Sabatini, D., et al. (2013). Rapalogs and mTOR inhibitors as anti-aging therapeutics. Journal of Clinical Investigation. [93] Silvestrini, M., Johnson, J., Kumar, A., et al. (2018). Nuclear Export Inhibition Enhances HLH-30/TFEB Activity, Autophagy, and Lifespan. Cell Reports. [94] Kishimoto, S., Uno, M., Okabe, E., et al. (2017). Environmental stresses induce transgenerationally inheritable survival advantages via germline-to-soma communication in Caenorhabditis elegans. Nature Communications. [95] Michal Horowitz (2015). Epigenetics and cytoprotection with heat acclimation. Journal of Applied Physiology. [96] Calabrese, V., Stella, A., Butterfield, D., et al. (2004). Redox Regulation in Neurodegeneration and Longevity: Role of the Heme Oxygenase and HSP70 Systems in Brain Stress Tolerance. Antioxidants and Redox Signaling. [97] Mark P. Mattson, Rehana K. Leak (2024). The hormesis principle of neuroplasticity and neuroprotection. Cell Metabolism. [99] Yutaka Matsui, Hiromitsu Takagi, Xueping Qu, et al. (2007). Distinct Roles of Autophagy in the Heart During Ischemia and Reperfusion. Circulation Research. [100] Kumsta, C., Chang, J., Lee, R., et al. (2019). The autophagy receptor p62/SQST-1 promotes proteostasis and longevity in C. elegans by inducing autophagy. Nature Communications. [101] Ji, S., Xiong, M., Chen, H., et al. (2023). Cellular rejuvenation: molecular mechanisms and potential therapeutic interventions for diseases. Signal Transduction and Targeted Therapy. [102] Justice, J., Ferrucci, L., Newman, A., et al. (2018). A framework for selection of blood-based biomarkers for geroscience-guided clinical trials: report from the TAME Biomarkers Workgroup. GeroScience. [103] Belsky, D., Caspi, A., Corcoran, D., et al. (2021). DunedinPACE: A DNA methylation biomarker of the Pace of Aging. [104] Ferrucci, L., González‐Freire, M., Fabbri, E., et al. (2020). Measuring biological aging in humans: A quest. Aging Cell. [105] Moqri, M., Herzog, C., Poganik, J., et al. (2023). Biomarkers of Aging for the Identification and Evaluation of Longevity Interventions. Cell. [106] Gkioni, L., Nespital, T., Baghdadi, M., et al. (2025). The geroprotectors trametinib and rapamycin combine additively to extend mouse healthspan and lifespan. Nature Aging. [107] Lee, D., Kuerec, A., Maier, A. (2024). Targeting ageing with rapamycin and its derivatives in humans: a systematic review. The Lancet Healthy Longevity. [108] Kuiper, L., Polinder‐Bos, H., Bizzarri, D., et al. (2023). Epigenetic and Metabolomic Biomarkers for Biological Age: A Comparative Analysis of Mortality and Frailty Risk. The Journals of Gerontology Series A.